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INTRODUCTION 
BACKGROUND 
 Among advanced economies, the United States (US) spends more per capita on 
healthcare than any other country, yet has consistently poorer health outcomes 
(Bloomberg, 2013).  Both per capita US spending and total healthcare spending as a 
percentage of gross domestic product remain the highest among industrialized nations 
(Fuchs, 2013). Health information technology (HIT) promises to help contain health care 
costs through improved efficiencies.  One source of inefficiency that HIT promises to 
address is the overuse of laboratory or diagnostic imaging tests because prior test 
information was not accessible to the physician at the time of the patient encounter 
(Stair, 1998). 
 Substantial financial investments are being made by the federal government to 
promote the productive use of electronic health record (EHR) technology, a specific 
class of HIT that, among other things, collects and stores patient clinical diagnosis and 
treatment information (Hayrinen, 2008; Jha, 2009; ISO/TR 20514).  This information can 
then be available to physicians electronically for use in providing subsequent diagnoses 
and care.  Nevertheless, because patients commonly receive care across multiple health 
settings or health systems with different EHRs, providers may still lack access to a 
patient’s prior test results and reorder tests which would not be necessary if the prior test 
results were accessible (Thomas, 2000; Gupta, 2010, Van Walraven, 2006).  Improved 
information sharing, enabled through EHR technology and health information exchange, 
present a reasonable mechanism that may lower the incidence of inappropriate tests 
resulting from a lack of physician access to prior test information.  This dissertation 
examines the impact of prior clinical information from an accessible EHR on problematic 
repeat medical testing. 
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 Medical testing, including laboratory and medical imaging tests, is costly with an 
estimated 4.3 billion tests performed in the US annually at a cost of $65 billion 
(Alexander, 2012).   Evidence exists that a substantial number of these tests may be 
redundant (Van Walraven, 1998; Bates, 1998b).  What constitutes redundant testing 
varies widely across studies. The most common definitions of redundant testing are 
based upon test frequency and timing with a correlation demonstrated between repeat 
tests and redundancy (Van Walraven, 2003; Zhi, 2013).  Both patient and physician 
factors have been shown to impact the frequency of redundant testing including: patient 
age, severity of illness, number of physicians placing orders, location of the patient 
assessment, test type and measurement criteria (Van Walraven, 2003).  Redundant 
testing patterns may vary substantially by age suggesting a need for further research 
(Van Walraven, 2003).  Understanding the mechanisms responsible for redundant 
testing may lead to lower rates of redundant testing. This can lower the burden on 
children, including the physical and mental impact of testing; improve patient care; and 
potentially lower the cost of care.  
 The timing of this research is important.  Under the Affordable Care Act (ACA), 
the Federal government introduced Accountable Care Organizations (ACOs) as an 
economic model designed to better align health care payments for services with efforts 
to improve care quality while constraining the total cost of care (HHS-CMS, 2011a,b).   
Under the accountable care model, healthcare systems are generally “attributed” a set of 
patients that consume resources both inside and outside that particular healthcare 
system making up a patient’s total cost of care.  ACOs are then held at least partially 
responsible for containing both the healthcare costs incurred by physicians and patients 
and the total patient costs paid for by the payer, while maintaining care quality.  
Economic incentives are realized by ACOs when they meet performance standards 
regarding both the quality and the cost of care.   Likewise, penalties are also incurred for 
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failure to achieve minimal thresholds of cost constraint and process and end-state 
outcomes.  Under this new model, the ACO has direct responsibility for influencing both 
(1) the consumption of health services and (2) administrative costs of delivering care to a 
customer population (Gold, 2011; CMS, 2011).  Health information technology can play 
an important role in helping health care organizations, including health systems and 
hospitals, achieve these goals.   
 
THE IMPACT OF HIT ON EFFICIENCY IN CARE DELIVERY 
 Understanding the economic benefits derived from HIT is a complex undertaking.   
The Institute for Healthcare Improvement (IHI) encapsulated the goals of healthcare 
improvement in the so-called “Triple Aim” objectives, including an emphasis on 
improving the efficiency of the health system.  The three-fold emphasis includes (1) 
improving health of the defined population (2) enhancing the patient care experience and 
(3) reducing or at least controlling the per capita costs of care (Berwick, 2008) 
 HIT investment, including the deployment of electronic health record technology, 
is seen as a critical component of achieving the Triple Aim objectives.  By Executive 
Order in 2004, the George W. Bush administration established the Office of the National 
Coordinator for Health Information Technology (ONCHIT) as a Department of Health and 
Human Services.   Passage of the American Recovery and Reinvestment Act (ARRA) 
and the related Health Information Technology Economic and Clinical Health (HITECH) 
Act in 2009 codified the position of national coordinator into law and provided  $2 billion 
to fund the ONCHIT and $19.2B to fund the EHR incentive program.  Beginning in 2011, 
Medicare and Medicaid now provide financial incentives to hospitals and physicians who 
can demonstrate a level of “meaningful use” of certified electronic health record 
technology (HHS-ONCHIT, 2012).  The Congressional Budget Office is projecting at 
least a doubling of adoption rates of electronic health records by physicians and 
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hospitals by 2019 to 90% and 70% respectively (Sunshine, 2009).  At these adoption 
levels, potential HIT-enabled efficiency savings was estimated at $77B annually across 
both inpatient and primary care (Hillestad, 2005) – suggesting the potential for full cost 
recovery of technology investments over time. 
 Early evidence from studies that looked at HIT support these policy efforts. 
Results of these studies were often favorable with demonstrated improvements in 
guideline compliance, enhanced monitoring, lower medication error rates, and improved 
economic efficiency through decreased utilization rates.  However, several researchers 
have noted that early analysis was based primarily upon the results of 4 “benchmark” 
institutions (Linder, 2007; Poon, 2010; Chaudhry, 2006).  Despite their success, these 
“homegrown” systems were unlikely options for most institutions that would deploy EHR 
technology and had limited generalizability (Chaudhry, 2006). 
 In 2007, the Agency for Healthcare Research and Quality (AHRQ) released an 
evidence report reviewing the results of 256 research studies to date addressing the 
costs and benefits of HIT (Shekelle, 2006).  While the report concluded optimistically that 
HIT would assist in a “dramatic transformation in the delivery of healthcare, making it 
safer, more effective and more efficient”, the authors also noted significant limitations in 
the “quality, quantity and generalizability of studies”.  Of the 256 studies, 15 were noted 
as either random or controlled clinical trials, with all of the 15 studies coming from 
benchmark institutions (Riegenstrief, Brigham and Womens, Intermountain Healthcare, 
Kaiser, Vanderbilt and the VA).  The results were considered “highly context specific”, 
limiting overall generalizability, given that these systems were unique and not 
commercially available.   Though all predicted savings from HIT deployment, studies of 
the economic value were limited to nine studies  – using multiple methods and differing 
assumptions – to arrive at their conclusions.   A specific lack of cost studies was cited 
among HIT deployments in pediatric hospitals.  Despite the limited evidence of cost 
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savings in pediatric hospitals, the report was “optimistic” regarding potential economic 
benefits to pediatric hospitals from investments in HIT (Shekelle, 2006). 
 Early national studies.  Two important national studies followed the AHRQ 
report and highlighted the challenge of measuring efficiency gains from HIT. 
Himmelstein (2010) looked at the relationship between hospital “computerization” and 
the costs and quality of care in a national study published in 2010.  This study involved 
the national selection of a diverse sample of hospitals.  The EHR construct was defined 
as “computerization” and was measured as a proportion of the number of fully 
implemented EHR functions for which data were available.  The 21-24 functions studied 
were grouped into three sub-scores or categories representing clinical, patient-related 
administration and other administration capabilities.  In addition to looking at quality, a 
cost construct was also included in the analysis to assess the impact of EHR 
deployment on hospital administrative costs.  The measurement applied was a 
proportion of the administrative costs of the hospital as a share of total costs.  Increased 
computerization was associated with a faster increase in administrative costs.   There 
was no evidence as well of a lagged effect between investment in technology and lower 
future costs, suggesting that technology investments increased the underlying 
administrative costs associated with delivering care (Himmelstein, 2010). 
 A second national study was published in 2010 that evaluated whether or not 
EHR adoption in hospitals was associated with better performance on a number of 
quality and efficiency measures (DesRoches, 2010).  In this study, the EHR construct 
was broken into three tiers and scored based upon adoption level: comprehensive, basic 
or no EHR adoption.   Information on specific functions – clinical decision support (CDS) 
and computerized physician order entry (CPOE) – were also captured for analysis 
purposes.  The cost or efficiency construct included several measurements: risk-
adjusted length of stay, risk-adjusted 30-day readmit, risk-adjusted inpatient costs and 
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observed to expected costs (measured as a ratio) adjusted for case mix, hospital 
mission and location.  Data for cost analysis was drawn from the 2006 Medicare 
Provider Analysis and Review (MEDPAR) information (HHS-CMS, 2014b).  As part of 
the study, an analysis was conducted on efficiency measures, using multivariate 
analysis to adjust for hospital characteristics.  Overall, no association was identified 
between EHR adoption and length of stay or readmits.  When examining pneumonia 
patients, hospitals with an EHR had a hospital length of stay (LOS) that was 0.5 days 
shorter (p<.003).  No significant cost differences were noted between EHR and non-EHR 
hospitals (p=0.22).  No significant differences were noted as well in analyzing risk-
adjusted cost ratios for any of the three conditions.  When adjusting for covariates, no 
significant associations were noted.  Similar analysis was conducted on the association 
between two specific functions, CDS and CPOE, and improvements in quality and 
efficiency measures.  These specific functions were associated with marginally better 
performance on each of the quality metrics (DesRoches, 2010). 
 Four more recent systematic reviews addressed both economic evaluation 
methods and cost outcomes.  Gallego (2010) conducted a systematic review 
summarizing cost and benefit indicators in economic evaluations (n=24 studies).  Bassi 
(2013) summarized economic indicators as well as the underlying economic methods 
used in health information economic evaluations (n=42 studies).  Black (2011) reviewed 
the impact of selected e-health functionality on benefits and costs from 1997-2010 (n=53 
studies). Finally, Buntin (2011) updated the earlier work by Chaudhry looking at specific 
economic outcomes associated with the deployment and use of HIT (n=154 studies).  
 Regarding cost outcomes from investment in health technology, Buntin reported 
that 92% of the recent articles published on HIT reached positive conclusions regarding 
one or more aspects of care.  Gallego found that prospective economic evaluations 
demonstrated that annual benefits were 76.5% of first year costs and >300% of annual 
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costs, suggesting a rapid capital-recovering process.  Annual benefits measured varied 
by study type.  While both results are optimistic, some significant limitations exist in the 
methods applied. Both reviews acknowledged the impact of publication bias that 
significantly underreports neutral or poor economic results.   Also, neither study followed 
a more traditional meta-analysis approach that provides corrected statistical measures 
for evaluating aggregated study results, including understanding the estimated 
aggregate impact of findings. 
 Black’s findings were more inconclusive noting only anecdotal evidence of the 
benefits of EHRs and CPOE on organizational or individual physician efficiency.  
Stronger positive results were found for ePrescribing, including improved efficiency and 
patient outcomes.  CDS’s were cited as a source of behavior modification but only weak 
evidence was referenced for its impact on care quality (Black, 2011).   
 A separate review of the results of ten recent individual studies was mixed 
(Jones, 2011; Lee, 2013; Connelly, 2012; Dowding, 2012; Teufel, 2010, 2012; Appari, 
2012; Furukawa, 2010, 2011; Zlabek, 2009) . Improvements were noted as statistically 
significant (due to sample size) but the magnitude was often small (Lee, 2013; Connelly, 
2012; Dowding, 2012).  The two pediatric hospital studies looking at hospital electronic 
medical record use and cost of inpatient pediatric care found that CPOE usage had no 
impact on cost of care (Teufel, 2010).  The second study used a four-staged 
classification for EHR (Stage 0: no automation – Stage 3: advanced EMR automation) 
by hospital that detected a seven percent increase in cost among more advanced EHR 
users (Teufel, 2012).  
 Categorizing the effect of EHR use on cost outcomes and efficiency.  Based 
upon the literature search conducted, three broad categories of potential cost outcomes 
through the use of HIT were identified. The first category includes the delivery of 
functionality that lowers the cost of delivering hospital-based care.  This includes 
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lowering the variable cost of service delivery per unit of care through functionality that 
simplifies the nature and length of the service provided (Connelly, 2011; Lee, 2013; 
Furukawa, 2010; Teufel, 2012).  It also includes renegotiating the price of labor or 
contracted services used to offer care (Furukawa, 2010) or better leveraging a fixed-cost 
infrastructure to capture productivity gains through increased scale.  Chaudhry (2006) 
cites reductions in clinician time spent as one of the primary cost outcomes of the 
introduction of HIT.  Menachemi and Collum cite reduced staff resources devoted to 
patient management, decreased transcription costs and costs related to chart pulls 
(Menachami, 2011). 
 The second is the delivery of functionality that alters physician behavior that 
lowers physician utilization of care, primarily through automating and informing the 
clinician order process using CPOE or medication management systems at the point of 
care.  Such benefits are important from both a payer and health system perspective.  
Benefits can be realized through accessibility of prior clinical knowledge available in 
medical records to inform clinicians regarding patient care.  These cost outcomes 
measure the elimination of errors or waste in the system as a result of unnecessary or 
redundant activities at the point of care.  Strong evidence from multiple studies 
demonstrates these technologies can lower physician demand for lab and radiology 
tests at the point of care, with absolute decreases ranging from 8.5 to 24.0% (Chaudhry, 
2006).   More recently, Zlabel (2011) found significant reductions in ordering of lab tests 
and radiology exams per week per hospitalization, as well as significantly lower monthly 
transcription costs at one site.  Connelly (2012) cites lower labs and prescriptions orders 
for heart failure patients in the emergency department.  While the results in this category 
are generally positive, one national study on hospitals that care for children noted no 
significant change in utilization based upon CPOE use (Tuefel, 2010). 
	   9	  
 The third category is the delivery of functionality that enables better physician or 
patient decision making regarding care that then leads to lower future consumption of 
healthcare services from a population perspective.  This category measures an 
intervention’s ability to lower demand for future health services while maintaining health 
outcomes.  This category may include maintaining healthcare consumption levels while 
improving health outcomes.  The category can also include  increasing short-term 
consumption, while increasing patient health outcomes at a more rapid pace in the long 
run, all with a goal to lower total cost of care over the patient’s life.  Arguably this third 
category could be viewed as a subset of category two though the emphasis here is on 
the long-term benefits of improved care and its impact on overall total patient cost of 
care from a population perspective.  Decision support capabilities that inform the 
clinician and impact both present and future decisions regarding patient consumption of 
services, are designed in part to meet this cost objective.  The presence of an EHR has 
been shown to impact readmission rates, impacting future service demand (Lee, 2013; 
Jones, 2011; Connelly , 2006; DesRoches, 2010).  Dowding cites the benefits of an EHR 
on reducing hospital-acquired pressure ulcers that introduce future health complications 
requiring care (Dowding, 2012).  Other examples include the potential impact of disease 
prevention, chronic disease management or care coordination programs on future 
demand for services (Katz, 2012; Auger 2013). 
 Of the three potential benefits associated with electronic health record use, this 
dissertation focuses on the second cost objective, lowering cost and improving care 
quality by studying impact that the presence of an accessible health record has on test 
repetition levels across a patient population.  More efficient use of medical testing across 
a patient population could lower per patient spending over time, an important measure in 
accountable care programs, and reduce future demand for treatment through improved 
care quality. 
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TEST REPETITION IN MEDICINE 
  Testing in medicine has several purposes including screening populations to 
identify health problems or the potential for health problems; supporting the diagnosis of 
illness or measure the progression of disease in a patient; and monitoring the impact of 
treatment on the human body in general and on the progress of the disease itself (Van 
Walraven, 1998). 
 Given the dynamic nature of a patient’s health state and the progressive nature  
of disease, repetition by clinicians of the same or similar tests with a given patient is 
common (Bates, 1998; Van Walraven, 1998).  Repeat testing occurs for a number of 
reasons including: a particular test requires multiple instances to obtain useful 
information, a  particular disease or treatment requires multiple results to obtain a clear 
understanding of disease progression or the impact of a health intervention or an initial 
test result is unclear or inconclusive requiring a repeat test.  Known risk factors that may 
influence the level of repetitive screening, diagnosis or treatment testing include age, 
sex, race, disease type/severity, purpose of the test, test type, presence of comorbidities 
particularly chronic conditions, the accuracy of the test itself, the acute or chronic nature 
of the condition, location of care and passage of time (Van Walraven, 2003; Zhi, 2013).  
 Not all repeat tests are necessary or appropriate for care resulting in both 
overtesting and undertesting.  Inappropriate testing may result from failing to administer 
either index or repetitive tests when such tests are warranted, for screening, diagnosis or 
treatment purposes (undertesting or missing tests).  Inappropriate testing may also result 
from administering index or repeat tests that are not required for necessary or 
appropriate care (often noted as redundant or excess testing) (Zhi, 2013). 
 Undertesting occurs when no testing is performed despite the presence of one or 
more indicators identifed in Table 1.  Undertesting may result in substandard patient 
care by failing to detect or diagnose the presence of a condition for which treatment is 
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available.  Failure to detect or rule out the presence of a disease or condition may result 
in poor quality of care and impact patient well being.  Evidence in a recent meta-analysis 
found that the risk of underutilization was almost twice the levels of over utilization 
(44.8% risk of underutilization versus 20.6% risk of overutilization across all test types) 
(Zhi, 2013). 
 
Table 1.  Indicators of undertesting (Zhi, 2013) 
 
  
 Bates, et al. defined redundant tests as those that “follow other tests of the same 
type, can be prospectively identified and have little chance of yielding clinically important 
information” (Bates, 1998b).  Overtesting or redundant testing has been shown to occur 
for a number of reasons noted in Table 2.  Overtesting is problematic for several 
reasons.  First, overtesting is an indication of substandard patient care given the near 
term potential physical impact that testing has on the patient.  Tests that are deemed to 
be unnecessary can create undue patient hardship resulting from test administration.  
Second, increased test utilization increases the risk of false-positive tests that may 
adversely impact patient well being.  Third, increased false-positive results can also give 
rise to the “Ulysses syndrome” which is defined as the tendency towards complete and 
aggressive work-ups to identify the health status and treatment plan for a patient who 
does not have the disease. This results in unnecessary economic cost associated with 
both administering the test as well as future medical costs for unnecessary downstream 
treatment (Rang, 1972; Dorevitch, 1992).   Physician ordering practices, including panel-
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based ordering and defensive medicine (Mello, 2010) are primary drivers of 
inappropriate testing (Epstein, 1986; Williams, 1982; McGillvray, 1993; Bugter-Maessen, 
1996; Griffith, 1997).  When examining testing from a population-based perspective 
across all care settings, one source of overtesting may result from a lack of clinician 
awareness of prior test results performed by other clinicians for a patient.  Without a 
mechanism for sharing prior test results, clinicians in this situation may repeat tests. 
 
Table 2.  Indicators of overtesting (Zhi, 2013) 
 
 One broad objective of federal subsidies to promote investments in electronic 
health record technology is to promote improved information sharing by clinicians  This 
is based upon the view that improved care coordination, including information sharing, 
leads to better health outcomes and lower healthcare costs. However, results remain 
mixed (Van Walraven, 2006; AMA, 2009; NQF, 2011).  Effective care coordination 
remains problematic in most developed countries (Schoen, 2011).  Since patients 
commonly receive care across multiple clinicians, often across multiple health settings or 
health systems with different EHRs, clinicians may lack access to a patient’s prior test 
results and, subsequently, reorder tests that would not be necessary if the prior test 
results were accessible.  Access to prior test results enabled through electronic sharing 
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of health information using a common EHR or through the exchange of prior test 
information between provider’s separate EHR’s using health information exchange 
should lower the incidence of inappropriate testing.   
Studies on the incidence of redundant testing in children, as well as the potential 
impact of information sharing in reducing redundant testing in this pediatric population, 
are particularly sparse.  Yet, evidence suggests that redundant testing patterns may vary 
substantially by age suggesting a need for further research (Van Walraven, 2003). 
Isolating the level of inappropriate or redundant testing that can be eliminated through 
better information sharing of patient test information, both within and among health 
systems that care for children, can improve care quality and lower cost. 
 
BASIS FOR UNDERSTANDING 
 Repetition by clinicians of the same or similar tests with a given patient is 
common and varies by age (Bates, 1998; Van Walraven, 1998).  However, not all repeat 
tests are necessary or appropriate for care (Zhi, 2013).  Inappropriate testing includes 
both overtesting and undertesting (Zhi, 2013).  Outcomes associated with overtesting 
include unnecessary physical and emotional hardship and economic cost that can justify 
efforts to eliminate unnecessary or potentially redundant tests (Rang, 1972; Dorevitch, 
1992)  .Limited evidence suggests that an electronic health record (EHR) may reduce  
redundant lab and radiology testing by making previous test results accessible to 
clinicians at the point of care (Bates, 1999).  Results of research on the impact of EHR 
use on radiology and lab testing in pediatric populations is limited and inconclusive 
(Tuefel, 2010a). 
 The impact of the accessibility of prior test results on redundant test levels has 
been examined in individual health system settings.  No studies were found linking 
accessibility of prior test results via an electronic health record with test redundancy in a 
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population-based study.  It’s generally accepted that children often receive care across 
multiple health systems.  Each individual health system has an EHR that contains the 
results of lab and radiology tests ordered by clinicians within that single health system.  
Lab and radiology tests for the same patient may be in different EHRs if they are cared 
for in different health systems.  Given this fact, lab and radiology test information is less 
likely to be available or accessible for the clinician at the point of care if the patient 
results are in more than one EHR within more than one organization  As a result, it is 
anticipated that a higher level of redundant testing exists among children receiving care 
from more than one health system than for children who receive care from one 
organization due to a lack of physician access to a patient’s prior test results. 
 
MEASUREMENT CONSTRUCTS 
 To provide a basis for understanding and to characterize this theory, several 
measurement constructs were defined.  A “test instance” was the unit of measure 
defined as any medical test performed by a clinician in a home care, primary care, 
outpatient, emergency room, inpatient, nursing home or other public health setting to 
provide information on a patients health status for screening, diagnosis, treatment or 
monitoring purposes.  A “repeat test instance” was defined as a second lab or 
radiology test that follows a preceding instance of the same test (index test) for the same 
patient during the study period.   This required an exact match of the index test and 
repeat test CPT (Current Procedure Terminology) code.  This approach precludes the 
matching of tests based upon the presence of test result information that may be 
available through related but different tests or through test panels. A “health system” 
was defined as a single network of clinics, hospitals, specialty programs and long-term 
care facilities under a common ownership structure designed to deliver health care.  An 
important characteristic of single health systems in this study population is the presence 
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of a distinct “electronic health record system” in each health system containing all 
information regarding patient care delivered within that health system (MDH, 2013ab). 
“Accessible prior test results” were deemed accessible to the clinician if the patient 
received all care within a single health system. “Facility type” characterizes the location 
where the index or repeat test instance was placed, including inpatient, outpatient, 
primary care or other facility type.   A “redundant test” is defined based upon Bates 
criteria as “tests that follow other tests of the same type, can be prospectively identified 
and have little chance of yielding clinically important information” (Bates, 1998).  
Identification of a redundant test typically requires that one has complete patient 
information, including the actual test values of index and repeat tests to correctly classify 
a test as redundant.  In population-based studies in the United States, test information is 
captured decentrally within an individual health system often making collection of test 
results impractical.  A “problematic repeat test” was defined for purposes of these 
studies and included any repeat tests with one or more characteristics that suggest a 
higher level of test redundancy.  Figure 1 clarifies the distinction between the different 
classifications of repeat tests with problematic repeat tests a subset of repeat tests.  
Useful criteria for problematic repeat tests is then designed using available population 
data to capture a significant majority of actual redundant tests within the population. 
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Figure 1.  Classifying repeat tests 
 
 
 Using these terms, a simple model was developed to provide context for further 
study as noted in Figure 2.  The model depicts patient ABC, a pediatric patient, receiving 
care from two distinct health systems, health system 1 and health system 2.  Each 
health system has a distinct electronic health record system (EHR 1 and EHR 2) that 
captures patient test information on patient encounters that occur within that health 
system.  In the model, patient ABC has three distinct test instances A, B and C.  Test 
instances A and C were performed within the same health system with test information 
for both tests captured in a single electronic health record system (EHR 1).  Test 
instances A and B were performed at separate health systems with data for each 
instance captured separately by the health system clinician that ordered the test 
performed. 
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Figure 2.  Contextual model for a pediatric patient receiving care from more than 
one health system 
 
 Examining Figure 2, three things are anticipated.  First, test instance B is more 
likely to be a repeat test instance of the same test than test instance C.  Second, the 
incidence of repeat test instances will be higher in patient ABC than in a second patient 
who receives all patient care within a single health system with a single electronic health 
record system.  Third, among the same facility types,  the likelihood that test instance B 
is a repeat test instance of the same test relative to test instance C remains significant.  
The working theory is that a portion of repeat test instances result from a lack of clinician 
access to prior clinical information observable within an EHR and that clinicians with 
access to prior clinical information through an EHR will order fewer repeat tests than 
clinicians who do not have access to prior clinical information.   For testing purposes, 
this general association can be characterized as noted in the visualization in Figure 3. 
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Figure 3.  Model of the association between the accessibility of prior test results 
available through an electronic health record system and the incidence of repeat 
test instances 
 
	    
 In conducting this evaluation, results described above may be observed but an 
association will by unclear without examining in more detail specific circumstances.  This 
may result from the presence of other potential risk factors that affect the ability to detect 
the impact of available prior clinical information on repeat test instances. These may 
include patient characteristics; test characteristics; disease characteristics; patient health 
care utilization characteristics; health system characteristics and electronic health record 
characteristics associated with both access to prior clinical results and the likelihood of 
repeat test instances (Van Walraven, 2003; Zhi, 2013).   
 Multivariate logistic regression provides a reasonable basis for modeling this 
association, including adjusting for other known risk factors that may be associated with 
care.  The two primary equations of multivariate logistic regression include the following: 
(Equation 1) 
 
π(X) = exp(β0+β1X1+β2X2+ … +βpXp)/ 
 (1 + (exp(β0+β1X1+β2X2+ … +βpXp)) 
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which gives us the probabilities of outcome events given the covariate values X1, X2, 
X3…Xp.  Transforming the dichotomous outcome using the logit transformation gives us 
a standard multivariate linear regression model as follows: 
(Equation 2) 
   logit(π(X)) = β0+β1X1+β2X2+ … +βpXp 
 
The outcome of the multivariate logistic regression model is the logit(π(X)) – a binary 
outcome variable (0/1) that allows us to compare the odds that a particular test instance 
is a repeat test instance based upon whether or not the patient received care within a 
single health system with a single EHR or across multiple health systems with results 
captured across multiple EHRs.  
 To examine the effect of a common health system and EHR on the incidence of 
repeat test instances by patient, an alternate regression modeling approach is required 
given the presence of a count variable identifying the number of repeat test instances by 
patient.  For these purposes, the use of a negative binomial regression is appropriate.  A 
negative binomial distribution is a discrete probability distribution of the number of 
successes in a series of trials before a non-random number of failures occurs.  Negative 
binomial regression is useful when dealing with over-dispersed discrete data and 
provides a more accurate estimator than simple Poisson regression in most cases (Du, 
2012). 
 
STUDY HYPOTHESIS 
 The underlying hypothesis for these population-based studies is that a portion of 
repeat test instances within a pediatric population result from a lack of clinician access to 
prior test results observable within an electronic health record.  Clinicians with access to 
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prior test results observable through an electronic health record will order fewer repeat 
tests than clinicians who do not have access to prior test results. 
 
SPECIFIC AIMS 
The aims of this research include the following:     
1. Aggregate all pediatric claims data for the defined study population for analysis 
and characterize the repeat test instances within the pediatric population, 
including the effect of multiple health system use by patient on the odds of repeat 
test instances generally; 
2. Measure the effect of facility type (i.e., hospital, outpatient primary care) as a risk 
factor on the effect of multiple health system use by patient on the odds of repeat 
test instances within the pediaric population; 
3. Define a reasonable criteria for problematic repeat tests for lead testing in 
children. 
4. Measure the effect of health system use on the incidence of problematic repeat 
lead testing to determine the impact that assumed access to a common health 
record may have on problematic test levels. 
 
 The first paper “Characteristics of Repeat Test Instances in a Pediatric 
Population” characterizes the nature of test repetition within a pediatric population in an 
effort to better understand the nature of repeat test instances and risk factors associated 
with repeat test instances, including the presence of an accessible electronic health 
record.  The study results identify important risk factors associated with repeat test 
instances in children and demonstrate that patients receiving care in one health system 
with an accessible electronic health record is associated with a significantly lower 
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incidence of repeat test instances than patients who receive care from multiple health 
systems with multiple electronic record systems. 
 The second paper, “Effect of Facility Type on the Risk of Repeat Test Instances 
in a Pediatric Population” examines the effect that facility type has on the association 
between patient use of multiple health systems and the level of repeat test instances.  
The study results demonstrate that facility type has a significant effect on the relationship 
between the presence of an accessible electronic health record and repeat test 
instances. 
 The third paper, “Effect of an Accessible Electronic Health Record on the 
Incidence of Problematic Repeat Lead Testing in a Pediatric Accountable Care 
Population” examines the impact that the accessibility of prior test results has on 
problematic repeat lead testing in a pediatric population.  The study defines a 
reasonable criteria for the detection of problematic repeat lead tests and characterizes 
the nature and level of problematic repeat lead tests within a pediatric population.  The 
study results demonstrate that use of a single health system with prior lead test results  
accessible through a common electronic health record is associated with significantly 
lower odds of problematic repeat lead testing. 
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SUMMARY 
Background 
Repetition by clinicians of the same or similar tests with a given patient is common.  
However, not all repeat tests are necessary or appropriate for optimal care.  Overtesting 
can result in unnecessary emotional hardship and economic cost.  Limited evidence 
suggests that an electronic health record (EHR) may reduce redundant lab and radiology 
testing by making previous test results accessible to physicians, though research on the 
potential effect in pediatric populations is sparse.  The purpose of this study is to 
characterize the nature and scope of repeat testing within a pediatric population and to 
identify significant risk factors associated with repeat test instances. 
 
Methods 
A retrospective cross-sectional design was used to measure initial and repeat test 
instances.  The study population consisted of a continuing Medicaid population cohort of 
12436 children (n=9153 patients with at least one test (68856 tests)) defined under a 
three-year demonstration project agreement between Children’s Hospitals and Clinics of 
Minnesota (CHC-MN) and the Minnesota Department of Human Services (DHS) from 
2012 to 2014. The study setting included all healthcare service organizations in the state 
of Minnesota that delivered health services to the defined study population and were 
reimbursed for services by the DHS under Medicaid. The study period was a one-year 
time frame ending September 30, 2013. Regression methods were used to test for 
significant associations between the outcome variable, repeat test instance and the 
primary explanatory variable health system use. 
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Results 
The overall test repetition risk during the study period was 26.24% (n=68856 total 
radiology and lab tests).  Pediatric patient characteristics significantly associated with a 
repeat test instance of the same test included age, residence, insurance plan type, test 
order location type, patient health status, patient test volume and availability of prior test 
results.  The odds that a test was a repeat test instance were significantly higher when 
patients received care from multiple health systems and patient care information was 
captured on multiple different electronic health record (EHR) systems [adjusted OR 1.30 
(95%CI: 1.25-1.35)]. Among patients with 25 or fewer test instances, the adjusted OR 
was 1.09 [95%CI: 1.02-1.15].  Similarly, the incidence of repeat test instances per 
patient was significantly higher when prior test results were not accessible [adjusted 
incidence rate ratio (IRR) 1.78 (95% CI: 1.66-1.91)].  Among patients with 25 or fewer 
test instances (n=8760 patients), the association between health system use and 
incidence of repeat test instances per patient during the study period remained 
statistically significant [adjusted IRR 1.40 (95% CI: 1.31-1.50)].  
 
Conclusions 
Pediatric patients who use more than one health system with patient information 
captured on more than one EHR have a higher level of repeat test instances of the same 
test than patients who receive all care within one health system using a single EHR. This 
may be due in part to a lack of clinician access to prior test results and is potentially 
redundant.  Both a common electronic health record and health information exchange 
are potentially useful tools in reducing the incidence of repeat test instances in 
populations that receive care from multiple health systems.  
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BACKGROUND 
 Repetition by clinicians of the same or similar tests with a given patient is 
common (Bates, 1998b; Van Walraven, 1998).  Repeat testing occurs for a number of 
reasons.  A particular test may require multiple instances to obtain useful information. A 
particular disease or treatment may require multiple results to obtain a clear 
understanding of disease progression or the impact of a health intervention over time.  
An initial test result is unclear or inconclusive requiring a repeat test.  Risk factors that 
influence the level of repetitive testing include patient demographic factors (including 
age, sex, race);  test-related factors (including the purpose of the test, the test type and 
test accuracy); the nature of the condition being studied (including disease type, disease 
severity, presence of comorbidities particularly chronic conditions); and other factors 
including the location of care and the passage of time (Van Walraven, 2003; Zhi, 2013). 
Studies on the incidence of repetitive testing in children are sparse.  Yet, evidence 
suggests that repetitive testing patterns may vary substantially by age (Van Walraven, 
2003). 
 Not all repeat tests are necessary or appropriate for care resulting in meaningful 
levels of both overtesting and undertesting.  Inappropriate testing may result from failing 
to administer either index or repetitive tests when such tests are warranted, for 
screening, diagnosis or treatment purposes (cited as undertesting or missing tests).  
Inappropriate testing may also result from administering index or repeat tests that are 
not required for necessary or appropriate care (often noted as redundant or excess 
testing) (Zhi, 2013). 
 Overtesting is problematic for several reasons.  First, overtesting is an indication 
of substandard patient care given the near term potential physical impact that testing has 
on the patient.  Tests that are deemed to be unnecessary can create undue patient 
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hardship resulting from test administration, particularly among children.  Second, 
increased test utilization increases the risk of false-positive tests that may impact patient 
well-being.  Third, increased false-positive results can also give rise to the “Ulysses 
syndrome” which is defined as the tendency towards complete and aggressive work-ups 
to identify the health status and treatment plan for a patient who does not in fact have 
the disease.    This results in unnecessary economic cost associated with both 
administering the test as well as future medical costs for unnecessary downstream 
treatment (Rang, 1972; Dorevitch, 1992).   Physician ordering practices, including panel-
based ordering and defensive medicine (Mello, 2010) are primary drivers of overtesting 
(Epstein, 1986; Williams, 1982; McGillvray, 1993; Bugter-Maessen, 1996; Griffith, 1997).  
  
 Examining patient testing from a population-based perspective across all care 
settings, one source of overtesting may result from a lack of clinician awareness of prior 
test results performed at other health care locations or by other clinicians.  Because 
patients commonly receive care across multiple health settings or health systems with 
different EHRs, providers often lack access to a patient’s prior test results and reorder 
tests that would not be necessary if the prior test results were accessible. Without a 
mechanism for sharing prior test results, clinicians in this situation may repeat tests. 
 Limited evidence suggests that an electronic health record (EHR) may reduce  
redundant testing by clinicians, including lab and radiology tests, by making previous test 
results accessible (Bates, 1999).  One broad objective of federal subsidies to promote 
investments in electronic health record technology, including Stage 3 meaningful use 
objectives, is to promote improved sharing of patient information, including test results, 
across health systems (HHS-ONCHIT, 2014).  This is based upon the view that 
improved care coordination including information sharing leads to better health 
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outcomes and lower healthcare costs, though results of such efforts remain mixed (Van 
Walraven, 2006; AMA, 2009; NQF, 2011).  
  
 The purpose of this study is to characterize the scope and nature of repeat 
testing within a pediatric population and to identify significant risk factors associated with 
repeat test instances in children, including measuring the impact of accessibility of prior 
test results available through an accessible medical record on repeat test instances.. 
The underlying hypothesis is that a portion of repeat test instances result from a lack of 
physician access to prior clinical information observable within a patient electronic health 
record (EHR) and may be redundant.  As a result, patients receiving care across multiple 
health systems, each with a separate electronic health record system, will have a higher 
incidence of repeat test instances. Reducing rates of potentially excess testing by 
improved sharing of patient information can lower the burden on children, including the 
physical and mental impact of testing; improve patient care; and potentially lower the 
cost of care.  IRB approval for this study was obtained from the Minnesota Department 
of Human Services (IRB# 280), Children’s Hospitals and Clinics of Minnesota (IRB# 
1402-022) and the University of Minnesota (IRB# 1403E49003). 
 
METHODS 
 The study objectives were to measure the prevalence of multiple lab and 
radiology test instances in a pediatric population and then to characterize significant 
patient, physician and test factors that may impact repeat test instances.  Differences in 
the level of repeat test instances were then tested between patients that have all tests 
performed within a single health system on a single electronic health record versus 
patients that have tests performed across multiple health systems each with a distinct 
electronic health record system. 
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 Several constructs were used for purposes of the study.  A “test instance” was 
the unit of measure for this study and was defined as any medical test performed by a 
clinician in a home care, primary care, outpatient, emergency room, inpatient, nursing 
home or other public health setting, to provide information on a patients health status for 
screening, diagnosis, treatment or monitoring purposes.  A “repeat test instance” was 
defined as a second lab or radiology test that follows a preceding instance of the same 
test (index test) for the same patient during the study period.   This required an exact 
match of the index test and repeat test CPT code.  This approach precludes the 
matching of tests based upon the presence of test result information that may be 
available through related but different tests or through test panels.  “Probability of 
repeat test instances” was defined as the probability that multiple instances of the 
same test are performed on the patient during the study period defined and was 
calculated by dividing the count of repeat test instances by the total test count.  Repeat 
test instances were analyzed by test instance and by patient.  “Days-to-next test 
instance” was defined as the number of days between the index test and the next test 
instance (next test instance date – index test date).  A “health system” was defined as 
a single network of clinics, hospitals, specialty programs and long-term care facilities 
under a common ownership structure designed to deliver health care.  An important 
characteristic of single health systems in this study population is the presence of a 
distinct electronic health record system in each health system containing all information 
regarding patient care delivered within that health system (MDH, 2013 a,b).  Given this, 
for purposes of this study, “accessible prior test results” were deemed accessible to 
the clinician via a common electronic health record if the patient received care from a 
single health system.  A “redundant test” is defined based upon Bates criteria as “tests 
that follow other tests of the same type, can be prospectively identified and have little 
chance of yielding clinically important information” (Bates, 1998b).  Identification of a 
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redundant test typically requires that one have complete patient information, including 
the actual test values of index and repeat tests to correctly classify a test as redundant.  
In population-based studies in the United States, test information is captured decentrally 
within individual health system making collection of test results impractical.  A 
“problematic repeat test” was defined for purposes of these studies using available 
information and included any repeat tests with one or more characteristics that suggest a 
higher level of test redundancy.  Figure 1 clarifies the distinction between the different 
classification of repeat tests. 
 A retrospective cross-sectional design was used to conduct the analysis.  The 
study population consisted of a Medicaid total population cohort of 15886 children 
defined under a three-year demonstration project agreement between Children’s 
Hospitals and Clinics of Minnesota (CHC-MN) and the Minnesota Department of Human 
Services (DHS) from 2012 to 2014.  CHC-MN is part of a distinct class of hospitals 
known as children’s hospitals that exist to exclusively serve the needs of children and 
adolescents.  Children’s hospitals are characterized by expertise in treating children, 
including children with rare diseases, and in providing greater attention to psychosocial 
support for children and families. 
 Patient attribution to the Medicaid patient cohort was based upon (a) Medicaid 
enrollment status and (b) whether the patient received a plurality of their care through 
CHC-MN primary care clinics.  Patient attribution for purposes of this study was 
measured as of December 31, 2013.  All test instance activity for this cohort represented 
by claims for laboratory services for the previous 12 months ending September 30, 2013 
was examined.  For purposes of this study, all patients that did not remain on Medicaid 
for the complete period of the study were excluded.  The final study population cohort 
consisted of 12436 patients with 9153 patients having at least one laboratory test claim 
(n=68856 total tests).  
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 The study setting includes all healthcare service organizations in the State of 
Minnesota that delivered health services to the defined study population and were 
reimbursed for services by the Minnesota Department of Human Services under the 
Medicaid program.  Care settings included hospitals, emergency rooms, medical 
centers, outpatient and primary clinics, home care, nursing homes and other long term 
care facilities, transportation assistance, public health agencies and other non-profit 
organizations. CHC-MN and its primary and specialty care network affiliates included in 
the demonstration project accounted for approximately 30% of the total health service 
charges attributed to the study population.  CHC-MN and its network affiliates accounted 
for approximately 70% of test order volume in the population.  EHR adoption is high 
within the provider population serving study patients.  The 2013 e-Health Survey 
conducted by the Minnesota Department of Health notes that 87% of clinics and 96% of 
hospitals, labs and local health departments have adopted electronic health record 
technology or equivalent health information technology (HIT) (MDH, 2013 a,b). The 
Department of Human Services provided patient and submitted claims data for all 
covered care paid by Medicaid provided to the patient cohort, including claims submitted 
by healthcare organizations or radiology and lab services for testing purposes.  EHR 
utilization data was provided by the Minnesota Department of Health (MDH, 2013 a,b). 
 Descriptive statistical methods were used to characterize the population and 
identify potential risk factors for repeat test instances in children.   The unit of analysis 
was either a test instance or a patient.  The outcome variable was defined two ways for 
test purposes: as a binary variable identifying the instance as a repeat test instance (0/1) 
and as an integer count of the total test repeats by patient.   Potential explanatory 
variables were identified for testing based upon known and potential patient, physician 
and test factors that may impact repeat test instances in adult populations including 
patient demographics (age, gender and residence); patient health status (number of 
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chronic conditions, general health status, number of health systems used and total 
patient test volume); and approach to care (care location, test type) (Van Walraven, 
2003; Zhi, 2013).  Patient general health status was measured by the resource utilization 
band classification system devised using the Johns Hopkins ACG system (Johns 
Hopkins, 2009).  The ACG system was designed to measure multi-morbidities and has 
been shown to have a strong correlation with overall patient health (Starfield, 2011). 
 The primary explanatory variable, health system use, was defined two ways for 
purposes of testing: as a binary variable (one health system/more than one health 
system) and as discrete integer variable based upon the number of health systems that 
performed tests for the patient.  An important characteristic of a single health system is 
the presence of a single electronic health record that contains all patient data. Services 
by clinicians were based upon the national physician identifier (NPI) code for the 
provider receiving payment for services (n=447).   Instances were then individually 
reviewed and grouped by health system (n=292 health systems), each with a unique 
electronic health record instance. Univariate and multivariate logistic regression were 
deployed to test for significant associations between explanatory variables and the 
outcome variable.  Negative binomial univariate and multivariate regression were used in 
analyzing patient-level counts of test instances.  Results by test instance and by patient 
were reported separately. 
 
RESULTS 
 Of patients that received at least one test, the patient population ranged from 
premature birth to 21 years with the majority of patients between 1-9 years of age (mean 
age 7.17 years (median 6.19)).   Fifty-one percent (51.94%) of patients were male with 
74.05% of the patient population living within the two-county metropolitan area including 
the urban centers of Minneapolis and St. Paul.   Over three-fourths of patients were part 
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of a Medicaid managed care plan (76.64%) versus Medicaid fee for service. Patients 
with at least one test performed had an observed higher incidence of chronic conditions 
and poorer health status than patients with no tests performed.  Patients had tests 
ordered from an average of between 1 and 2 health systems with 32.84% of patients 
using more than one health system. A complete description of the study population is 
noted in Table 3. 
 
Table 3.  Study population characteristics 
 
  
 Total test instances were 68856 that included 57997 lab instances (84.23%) and 
12869 radiology instances (15.77%), or an average of 6.34 lab instances and 1.19 
radiology instances per patient with at least one test.  Test instance volume range per 
person during the study period was considerable (lab instances: 0 – 419 & radiology 
instances: 0 – 79).   Repeat test instances accounted for 26.24% of the total test 
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population. Population characteristics significantly associated with risk of repeat test 
instances as noted in Table 1 included both mean age at visit (in years) and by age 
group, urban residence, use of a managed care Medicaid plan.  Looking at the impact of 
patient heath status, each one-unit increase in the number of chronic condition counts 
(reference count = 0) was associated with a significant increase in the risk of a repeat 
test instance.  Similarly, patients with a higher estimated resource utilization band as 
measured by the modified ACG score referenced earlier were at increasingly greater risk 
of repeat test instances with each one unit increase in the band category (reference 
band = 1).   
 As anticipated, the probability of repeat test instances increased as the days to 
next-test-instance increased.  As noted in Table 2, nine percent (9%) of repeat test 
instances occurred within 1 day - 22% of multiple instances occurred within 7 days of the 
first test instance and 44% occurred within 30 days.  Mean days to next test instance 
was 67.73d.  Average days to next test instance varied significantly between lab and 
radiology tests with mean days to next test instance for lab tests 1.31 times longer 
(95%CI: 1.255 – 1.386) than for radiology tests with the majority of the difference coming 
within the first seven days of the index test as noted in Table 4. 
 
Table 4.  Repeat test instances by lab and radiology by days to next test instance  
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 Observed probability of repeat test instances was also found to vary considerably 
with the observed odds of a repeat test instance occurring in a hospital setting (53.40%), 
more than double the observed probabilities of outpatient, primary care and other test 
instance location types as noted in Table 5. 
 
Table 5.  Repeat test instances by facility type – overall and by laboratory and 
radiology testing 
 
 
 
 Observed variation by test type was meaningful with therapeutic drug assays, 
tissue typing and drug testing having the highest probability of repeat test instances.  
Among the top five most common test groups (microbiology, chemistry, hematology, 
organ or disease-oriented panels and urinalysis), observed probability of repeat test 
instances ranged from 25-30% over the study period as noted in Table 6. 
 
Table 6.  Repeat test instances by CPT lab group classification 
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 Looking at specific labs tests by Current Procedural Terminology (CPT) code 
2012 edition, the most common lab tests performed were strep, culture screens (related 
to strep testing), blood count (both hemoglobin only and complete) and lead testing as 
noted in Table 7. 
 
Table 7.  Multiple lab test instances by most common CPT code 
 
Meaningful differences in the observed probability of repeat test instances by imaging 
platform and individual test were apparent as well.  The majority of radiology tests 
performed were radiography tests (77.10% of all tests) with a probability of repeat test 
instances of 28.78%.  The next most common tests were ultrasound and computerized 
tomography (CT) as noted in Table 8. 
 
Table 8.  Repeat test instances by CPT radiologic code sub-category 
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The most common tests included the both the single and two-view chest x-ray, x-ray of 
the abdomen, computerized tomography (CT) of the head/brain and x-ray of the foot.  
These same tests had the highest repeat test instances as well as noted in Table 9. 
 
Table 9.  Multiple radiology test instances by most common CPT code 
 
 Patients had tests ordered from between 1 and 11 unique health systems.  
Observed probability of repeat test instances involving patients using one system was 
20.0% versus 31.1% for instances involving patients having test claims filed from more 
than one health system [OR 1.81 (95% CI: 1.74-1.87)].  Adjusting for confounding 
factors noted earlier, including total patient test instance volume, the difference remained 
significant [OR 1.30 (95% CI: 1.25-1.35)] as noted in Table 10.   
 Repeat test instance patterns reveal at least two underlying health care 
processes.  Focusing on patients with 25 or fewer instances (n=8760) improves the 
ability to detect the probability that repeat test instances were due to patient use of 
multiple health systems rather than from scheduled test instances associated with 
children who have severe comorbidities. The odds of repeat test instances remained 
marginally significant for patients with 25 or fewer test instances as well at 1.09 [95% CI: 
1.02-1.15]. 
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Table 10.  Unadjusted and adjusted odds ratio of a repeat test instance given 
patient used more than one health system 
 
	    
 
 Using negative binomial regression to measure the estimated incidence rate ratio 
of repeat test instances per patient, comparing patient using multiple health systems 
versus one health system, holding other variables constant, patients using multiple 
health systems had an incidence rate of repeat test instances that was 4.10 (95% CI 
3.73-4.50) greater than for patients using a single health system. The significant positive 
association remained after adjusting for covariates [1.79 (95% CI: 1.66-1.91)] as noted in 
Table 11.  On an adjusted basis, the association between health system use and 
incidence of repeat test instances during the study period remained significant at 1.40 
[95% CI: 1.31-1.50] as noted in Table 11. 
 
Table 11.  Incidence rate ratio of repeat test instances per patient between patients 
using multiple health systems and patients using a single health system 
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 Stratifying the multiple test incidence rate ratio by the number of health systems 
seen by patient, a significant positive association was observed between the number of 
systems used by each patient and repeat test instance levels.  The association remained 
after adjusting for identified risk factors as noted in Figure 4. 
 
Figure 4.  Odds of repeat test instances by patient by count of health systems 
used 
 
 
 
DISCUSSION 
 Repeat test instances are often essential to quality care for screening, diagnosis 
and monitoring (Van Walraven, 1998; Bates, 1998; Zhi, 2013).  The population-based 
results indicate that pediatric patients that receive care across multiple health systems 
supported by separate electronic health record instances have higher levels of repeat 
test instances after adjusting for identified risk factors.  
 Overall probability of repeat test instances was lower in the sample (26.24%) 
relative to studies of adult populations. Previous studies of population-based repeat test 
instances in adults in Canada measured the probability of repeat test instances at 56% 
for a set of 8 common tests (Van Walraven, 2003).  A separate community-based study 
found a probability of repeat test instances of 38% over an eight-month period (Branger, 
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1995).  Both these rates are higher than the levels identified in this study.  Distinctions in 
adult versus children’s health and health care may account for some of this variation. 
Pediatric care is focused on the growth and development of children thus impacting the 
nature and frequency of testing. Three of the top five most common lab tests found in 
the pediatric population are associated more commonly with childhood conditions (rapid 
strep, strep culture and lead testing) and were not included in a population-based study 
sample of common tests used to evaluate study repetition in adults (Van Walraven, 
2003).  More generally, evidence regarding differences in utilization patterns between 
adults and children are limited and the results are mixed.  For example, evidence 
regarding differences in ICU utilization patterns in a hospital-based study between 
children and adults cite better mortality results for children but no significant differences 
in resource utilization patterns and overall treatment cost between the two groups 
(Seferian, 2001). 
 Consistent with studies in adults, certain factors were significantly associated 
with repeat test instances in children.  Repeat test instances were associated with age, 
with patients greater than one-year old having significantly more repeat test instances 
than patients under the age of one.  Repeat test instances were also associated with 
patient residence, with those in urban areas at slightly higher risk of repeat test 
instances. The health plan financing arrangement was also associated with increased 
risk of repeat test instances with Medicaid fee for service patients having a higher 
incidence of repeat test instances.  Medicaid fee for service has been linked with 
increased utilization by physicians given the reimbursement structure in place that 
rewards utilization (Bindman, 1999; Gosden, 2000; Phillips, 2014). 
 Higher repetition levels for tests performed in a hospital were consistent with 
findings in larger adult populations (Valenstein, 1988; Bates, 1998a; Van Walraven, 
2003).  Higher levels of repeat test instances in hospital-based care may be, to some 
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degree, a function of the underlying conditions being treated and the underlying process 
of care.  A short-term increase in repeat test instances is often associated with hospital-
based care processes.  The underlying care processes that drive short-term repetition in 
a hospital setting may differ substantially from factors that drive repeat test instances in 
other care settings. Hospital-based factors may include for example the presence of 
automated workflows or clinical pathways, including standard test order sets, that may 
institutionalize test repetition in inpatient care (Niazkhani, 2009; Maslove, 2011). 
  The population-based results support the underlying theory that a test for the 
same patient at a different health system on a different EHR is 1.3 times more likely to 
be a repeat test [adjusted OR 1.30 (95%CI:1.25-1.35)] than if the test were ordered by 
the same health system with accessible prior test results.  Consistent with this, results 
also confirmed the hypothesis that the incidence of repeat test instances is higher 
[adjusted OR 1.79 (95%CI:1.66-1.91)] for patients having tests ordered from more than 
one health system where prior test results may not have been accessible.   A high level 
of repeat test instances is associated with the care of children with multiple co-morbid 
conditions.  Patients with more than 25 tests (n=393, 4.29% of population) during the 
study period were found to have more severe co-morbid conditions, often receiving 
home-based or nursing care. These children have significant prescribed test repetition 
associated with ongoing monitoring of health conditions.  Removing this sub-group of 
patients from the general population, a better measure of the effect of an accessible 
health record on patients with mild to moderate chronic illness or more common 
childhood illnesses that may have regular yet unplanned and fragmented care across 
multiple health systems could be performed.  The results suggest that when stratifying 
the population to remove patients with prescribed test repetition associated with multiple 
co-morbid conditions, the adjusted odds of repeat test instances for patients receiving 
care from more than one health system presumably without accessible test results 
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remains significant drops to 1.09 [95%CI: 1.02-1.15] .  Similarly, the incidence rate ratio 
of patients with multiple tests results remains significant but also drops [1.40 (95%CI: 
1.31 – 1.50)].   
 The fact that each health system has a separate electronic health record system 
makes it particularly difficult to separate the impact of accessible test results from an 
electronic health record from the effect of each health system’s policies and practices on 
the incidence of repeat test instances.  This gives rise to a possible alternative 
explanation for these results.  Health information technology enables innovation but only 
to the extent that HIT availability aligns with the human decision-making needs of an 
organization.  Evidence suggests that physicians will seek information only if it’s deemed 
to be relevant to the decision at hand, reliable in terms of information quality and timely 
(Andrews, 2005; Coumou, 2006).  Clinicians, for example, may have accessible test 
results from another health system but still elect to repeat tests as a matter of preference 
given concerns regarding the relevance and reliability of the test data or due to health 
system policy that encourages clinicians to repeat tests using only health system testing 
resources. The impact is that some portion of the incremental test repetition identified 
through this study may result from these mechanisms thus making it difficult to estimate 
the effective impact that making prior test results accessible through either a single 
electronic health record or through the health information exchange will have on the 
incidence of repeat test instances.   Future study is required to separate the effect of 
health system policy from the impact of accessible prior test results on the level of repeat 
test instances. 
 
LIMITATIONS 
 The cohort being studied is based upon an attribution formula that assigns 
patients to the ACO based upon (1) participation in a complex care coordination program 
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in place (selection of CHC-MN to receive care) and (2) plurality of care given at a 
children’s hospital/clinic.  Given that patients can elect where they receive a majority of 
their care, patients in effect self-select to the attributed population.  This may impact the 
generalizability of external validity of the study results.   
 Children’s hospitals have a set of potentially distinct patient and treatment 
characteristics from general hospital including the setting, patient demographics, the 
nature and severity of conditions treated and distinct protocols or pathways in place 
(Meurer, 1998; Merenstein, 2005).  Care should be taken in applying these results 
across a general pediatric hospital population.  
 Limitations in the secondary use of Medicaid claims data for research are cited 
by some as problematic when it comes to claim accuracy and the lack of clinical 
specificity with regards to diagnoses and underlying test results (Hsia, 1988; Seiber, 
2007; Chisholm, 2009; HHS-CMS, 2013).  Standard audit processes for testing Medicaid 
claims error rates occur annually.  The PERM (Payment Error Rate Measurement 
program) is sponsored by CMS and involves state evaluations on a rolling three-year 
test cycle.  As of the 2010 test cycle (which includes Minnesota), the national error rate 
for payment was 1.89% +/- 0.62%. (range from 1-3%).  State results range from 0.6 to 
3.8%.   Overall, Medicaid views these national results optimistically suggesting that no 
systemic problems exist in the results (Chisholm, 2009).  Enrollment continuity, often 
cited as a problem in using Medicaid data, was addressed by limiting the population to 
those patients who were enrolled for at least 12 months (Crystal, 2007). Regarding the 
lack of complete information, such limitations are more a function of the nature of the 
study being conducted that uses the claims data than of the underlying limitations of the 
data itself (Dombkowski, 2012; Cooke, 2013).   For purposes of this evaluation, the 
population-based approach to this study should limit the effect of limitations in the use of 
Medicaid claims data on the results of the study. 
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 Information risk is also present based upon the use of test panels for 
administering testing services.  It is possible that actual repeat test instances of useful 
comparable individual test measurements are higher than the results.   In a separate 
analysis, repeat test instance levels were 54% higher when matching a simple index 
hemoglobin blood test (CPT: 85018) against any repeat test instance that includes an 
individual hemoglobin test measurement, including test panel results. The effect of this 
limitation would be to underestimate the prevalence of repeat test information in this 
study.  This could impact the findings of this analysis if panel use varied significantly 
between index and repeat pairings within the same health system from pairings between 
two different health systems.  If certain locations are more likely to use panels and these 
locations were more likely to be paired as either same or different, then there would be 
an effect.  Further research is needed to define a meaningful approach to incorporating 
panel results in the study of test repetition and redundancy.   
 The statistical methods used for this study do not fully address the impact of 
correlated data on study results.  Naturally occurring groups such as patients and health 
systems may have more similar observations than different groups. The lack of 
independence between individual study samples (in this case, test instances) may lead 
to differences in the standard errors that can impact study results (Hanley, 2003; 
Sainani, 2010). Several mitigating factors may reduce the potential effect of clustering on 
these study results. The primary explanatory variable (patients who use one health 
system versus patients using more than one health system) was already partially 
aggregated to weight for the effect of patient clustering.  Also, patient-level analysis of 
the incidence rate ratio of repeat test instances per patient remained significant.  
However, further analysis is required to fully account for the impact of health-system 
groups on study results.  
 Changes in the approach to care delivery resulting from the presence of an 
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accountable care agreement could influence study results. While agreement terms are 
confidential, under the agreement CHC-MN is increasingly accountable for the total cost 
of care of this patient population during the term of the agreement.  As part of conducting 
this study, the author performed a complete review of the agreement to assess material 
terms or conditions that might impact study results.  No material issues were identified. 
 
CONCLUSIONS 
 While repeat test instances are valid for a number of clinical reasons, this study 
provides initial evidence that some portion of incremental test repetition among pediatric 
patients results when a patient visits multiple health systems.  This may be due in part to 
a lack of physician access to prior test results and may be potentially redundant.  Further 
research is needed to examine the underlying etiology of repeat test instances by 
examining the impact that test order location and individual test type has on these 
results.  Research is also needed to better understand the impact that hospital policy 
may have on the effectiveness of using accessible prior test results in practice. 
Quantifying the impact that access to prior clinical results has on the incidence of repeat 
test instances, as well further identifying the barriers to improved information sharing, 
can assist policymakers in defining clear benefits to health information technology 
solutions such as health information exchange.  Accessibility to prior test results enabled 
through a common electronic health record or through health information exchange may 
prove an important mechanism in efforts to promote safe and efficient delivery of 
healthcare by reducing the incidence of unnecessary repeat test instances.   
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SUMMARY 
 
Background 
Recent study results indicate that the odds of repeat test instances increase in a 
pediatric population that receives care from more than one health system than when 
treatment is provided within a single health system with an accessible electronic health 
record.  Meaningful variation was found in the odds of test repetition by facility type with 
the risk of test repetition higher in hospitals than in outpatient, primary care or other 
facility settings.  Higher test repetition levels in hospitals were consistent with findings in 
adult populations. The purpose of this study is to characterize the impact that facility type 
has on the association between patients receiving care from more than one health 
system and repeat test instances.  These findings can support population-based 
research into the benefits of health information technology, including health information 
exchange, designed to improve care quality and lower the cost of medical testing. 
 
Methods 
A retrospective cross-sectional design was used to measure repeat test instances by 
facility type.  The study population consisted of a continuing Medicaid population cohort 
of 12411 children (n=9128 patients with at least one test (66494 tests)) defined under a 
three-year demonstration project agreement between Children’s Hospitals and Clinics of 
Minnesota (CHC-MN) and the Minnesota Department of Human Services (DHS) from 
2012 to 2014. The study setting included all healthcare service organizations in the state 
of Minnesota that delivered health services to the defined study population and were 
reimbursed for services by the DHS under Medicaid. The study period was a one-year 
time frame ending September 30, 2013. Regression methods were used to test for 
significant associations between the outcome variable, repeat test instance, and the 
primary explanatory variable, patient health system use.. 
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Results 
This study confirmed that facility type has a significant impact on the risk of repeat test 
instances with inpatient care associated with higher risk of test repetition than outpatient 
and primary care settings.  Comparing same facility pairs, within inpatient facility types, a 
significantly lower risk of repeat test instances was observed when the health system 
differed [OR 0.58 (95%CI: 0.45-0.74)].  This may be due to a single tertiary care hospital 
dominating the repeated tests in this category.  Within outpatient facility types, no 
significant difference was observed when the health system differed. Within primary care 
facility types, higher odds of repeat test instances was observed when the health system 
differed [OR 1.32 (95%CI:1.18-1.47)].   
 
Conclusions 
Facility type has a significant impact on the risk of repeat test instances and may act as 
a surrogate measure for care intensity. Examining repeat pairings by same facility type, 
the health system effect remained evident in primary care settings suggesting that 
patients receiving primary care from more than one health system, presumably without 
access to prior test results, have an increased risk of repeat test instances.  These 
results provide preliminary evidence of the potential benefits of leveraging health 
information technology, including health information exchange, in primary care settings. 
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BACKGROUND 
 
 Repetition by clinicians of the same or similar tests with a given patient is 
common (Bates, 1998b; Van Walraven, 1998).  Repeat testing occurs for a number of 
reasons.  A particular test may require multiple instances to obtain useful information. A 
particular disease or treatment may requires multiple results to obtain a clear 
understanding of disease progression or the impact of a health intervention over time.  
An initial test result is unclear or inconclusive requiring a repeat test.  Risk factors that 
influence the level of repetitive testing include: patient demographic factors (including 
age, sex, race);  test-related factors (including the purpose of the test, the test type and 
test accuracy); the nature of the condition being studied (including disease type, disease 
severity, presence of comorbidities particularly chronic conditions); and other factors 
including the location of care and the passage of time (Van Walraven, 2003; Zhi, 2013). 
Studies on the incidence of repetitive testing in children are sparse.  Yet, evidence 
suggests that both repetitive testing patterns may vary substantially by age (Van 
Walraven, 2003). 
 Not all repeat tests are necessary or appropriate for care resulting in meaningful 
levels of both overtesting and undertesting.  Inappropriate testing may result from failing 
to administer either index or repetitive tests when such tests are warranted, for 
screening, diagnosis or treatment purposes (undertesting or missing tests).  
Inappropriate testing may result from administering index or repeat tests that are not 
required for necessary or appropriate care (often noted as redundant or excess testing) 
(Zhi, 2013). 
 Overtesting is problematic for several reasons.  First, overtesting is an indication 
of substandard patient care given the near term potential physical impact that testing has 
on the patient.  Tests that are deemed to be unnecessary can create undue patient 
hardship resulting from test administration, particularly among children.  Second, 
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increased test utilization increases the risk of false-positive tests that may impact patient 
well being.  Third, increased false-positive results can also give rise to the “Ulysses 
syndrome” which is defined as the tendency towards complete and aggressive work-ups 
to identify the health status and treatment plan for a patient who does not in fact have 
the disease.    This results in unnecessary economic cost associated with both 
administering the test as well as future medical costs for unnecessary downstream 
treatment (Rang, 1972; Dorevitch, 1992).   Physician ordering practices, including panel-
based ordering, lab order sets, and defensive medicine are primary drivers of overtesting 
(Epstein, 1986; Williams, 1982; McGillvray, 1993; Bugter-Maessen, 1996; Griffith, 1997; 
Mello, 2010).   
 Examining patient testing from a population-based perspective across all care 
settings, one source of overtesting may result from a lack of clinician awareness of prior 
test results performed at other health care locations or by other clinicians.  Because 
patients commonly receive care across multiple health settings or health systems with 
different EHRs, providers often lack access to a patient’s prior test results and reorder 
tests that would not be necessary if the prior test results were accessible. Without a 
mechanism for sharing prior test results, clinicians in this situations may repeat tests. 
 Limited evidence suggests that an electronic health record (EHR) may reduce  
redundant testing by clinicians, including lab and radiology tests, by making previous test 
results accessible (Bates, 1999).  One broad objective of federal subsidies to promote 
investments in electronic health record technology, including Stage 3 meaningful use 
objectives, is to promote improved sharing of patient information, including test results, 
across health systems (HHS-ONCHIT, 2014).  This objective is based upon the view that 
improved care coordination including information sharing leads to better health 
outcomes and lower healthcare costs, though results of such efforts remain mixed (Van 
Walraven, 2006; AMA, 2009; NQF, 2011).  
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 Earlier research examining the odds of repeat test instances by facility type found 
meaningful variation in the odds of test repetition with the risk of test repetition higher in 
hospitals than in outpatient, clinic or other care settings (Knighton, 2014).  Higher 
repetition levels for tests performed in a hospital were consistent with findings in adult 
populations and results in large part from variations in care intensity among different 
health care settings or facility types (inpatient, outpatient, primary care and other facility 
types) (Valenstein, 1988; Bates, 1998b; Van Walraven, 2003).  Variation then in facility 
type may mask the true effect of multiple health system use on the risk of repeat test 
instances.  The working assumption for this study is that facility type is a surrogate 
measure for care intensity with higher care intensity environments such as inpatient 
settings associated with a higher risk of test repetition. By measuring the risk of repeat 
test instances by facility pairs, better characterization of the effect that using multiple 
health systems has on the risk of repeat test instances in certain healthcare settings can 
be observed.  Understanding the effect by facility type can aid in targeting tangible 
opportunities to improve quality and lower cost of medical testing from EHR deployment 
and health information exchange.  IRB approval for this study was obtained from the 
Minnesota Department of Human Services (IRB# 280), Children’s Hospitals and Clinics 
of Minnesota (IRB# 1402-022) and the University of Minnesota (IRB# 1403E49003). 
 
METHODS 
 Several constructs were used for purposes of the study.  A “test instance” was 
the unit of analysis for this study defined as any medical test performed by a clinician in 
a home care, primary care, outpatient, emergency room, inpatient, nursing home or 
other public health setting to provide information on a patients health status for 
screening, diagnosis, treatment or monitoring purposes.  “Repeat test instances” were 
defined as a second lab or radiology test that follows a preceding instance of the same 
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test (index test) for the same patient during the study period. This required an exact 
match of the index test and repeat test CPT code.  This approach precludes the 
matching of tests based upon the presence of test result information that may be 
available through related but different tests or through test panels.  A “pair or pairing” is 
a combination of an index and repeat test instance of the same facility type.   
“Probability of repeat test instances” was defined as the probability that multiple 
instances of the same test are performed on the patient during the study period defined 
and was calculated as the count of repeat test instances divided by the test count. A 
“health system” was defined as a single network of clinics, hospitals, specialty 
programs and long-term care facilities under a common ownership structure designed to 
deliver health care.  An important characteristic of single health systems in this study 
population is the presence of a distinct electronic health record system in each health 
system containing all information regarding patient care delivered within that health 
system (MDH, 2013 a,b). For purposes of this study, “accessible prior test results” 
were deemed accessible to the clinician via a common electronic health record if the 
patient received care from a single health system. A “redundant test” is defined based 
upon Bates criteria as “tests that follow other tests of the same type, can be 
prospectively identified and have little chance of yielding clinically important information” 
(Bates, 1998b).  Identification of a redundant test typically requires that you have 
complete patient information, including the actual test values of index and repeat tests to 
correctly classify a test as redundant.  In population-based studies in the United States, 
test information is captured decentrally within individual health system making collection 
of test results impractical.. 
 Facility type was defined as the healthcare location that ordered the test.  In this 
study four primary facility types were examined – inpatient, outpatient, primary care and 
other facility type. Facility type was classified based upon the defined algorithm 
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presented below.  Two existing claims fields were used in classifying test orders based 
upon their source using administrative data: 
1. Place of Service (POS) is an existing classification structure used by Medicaid for 
billing purposes to identify the physical location where the services were 
delivered.   
2. Bill type is an existing classification structure used by Medicaid that includes the 
physical location of service, primarily for hospital billing purposes.  Bill type is a 
four-digit identifier with each digit having a specific value.  The first digit identifies 
the physical facility type (hospital, clinic, home health, etc.), the second identifies 
more specific facility designation and the third digit identifies the nature of the 
billing itself.  This designation is useful primarily for further classification of items 
that do not have a place of service code. 
From this, the following classification structure was developed as noted in Table 12 for 
classifying test instance by facility type.   
 
Table 12.  Identification algorithm for test instance by facility type 
Facility type Description 
Inpatient • Test instances associated with a POS 21 code (inpatient hospital) 
• Test instances associated with an encounter without a POS code but 
with a bill type of 851 (critical access facility) 
Outpatient • Test instances associated with POS 22 (outpatient hospital) 
• Test instances associated with an encounter without a POS but with a 
bill type of 131, 141 and 831 (regular outpatient, outpatient diagnostic 
and ambulatory surgery centers, respectively 
• Test instances associated with POS 23 (emergency room)  
• Test instances associated with hospital/renal care with no POS but 
with bill type 721 
Primary care • Test instances associated with a POS of 11 (office visit) 
• Any test instance associated with an encounter with a bill type of 7 
(clinic)   
• Any test instance associated with POS 20 (urgent care) 
Other facility types • Includes all test instances coded with another classification 
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 “Other facility type” included a mix of different facility types, including schools, 
public health agencies and other community providers.  This classification allows not 
only for repeated testing within facility type but also across quite different facilities within 
the category.  Since the focus of this paper is to examine the impact of same versus 
different health systems within facility type, the “Other facility type” was not included in 
the examination of these effects. 
 Study objectives included measuring the risk of repeat test instances by facility 
type – inpatient, outpatient, primary care and other facility type categories. Further the 
potential effect multiple health system use would have on the risk of repeat test 
instances for three facility types – inpatient, outpatient and primary care was separately 
measured.  A simplified model of the relationships is noted in Figure 5. 
 
Figure 5.  Model of index and multiple test instance pairings for a given facility 
type. 
 
 
	   	    
 
 A retrospective cross-section design was used to conduct the analysis.  The 
study population included a Medicaid total population cohort of 15886 children defined 
under a three-year demonstration project agreement between Children’s Hospitals and 
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Clinics of Minnesota (CHC-MN) and the Minnesota Department of Human Services 
(DHS) from 2012 to 2014.  CHC-MN is part of a distinct class of hospitals known as 
children’s hospitals that exist to exclusively serve the needs of children and adolescents.  
Children’s hospitals are characterized by expertise in treating children, including children 
with rare diseases, and in providing greater attention to psychosocial support for children 
and families. 
 Patient attribution to the Medicaid patient cohort was based upon Medicaid 
enrollment status and whether the patient received a plurality of primary care through 
CHC-MN.  Patient attribution for purposes of this study was measured as of December 
31, 2013.  All test instance activity for the previous 12 months ending September 30, 
2013 was included in the data files and analyzed.  For purposes of this study, all patients 
that did not remain on Medicaid for the complete period of the study were excluded.   
Examining outpatient test instances, a subset of renal patients (n=25) 
responsible for a high level of appropriate test repetition associated with scheduled renal 
dialysis routinely performed in a distinct health system’s dialysis facility were removed.  
These test instances were removed for analysis purposes out of concern that they would 
impact the ability to detect repetition associated with more random testing patterns 
across the population.  The final study population cohort included 12411 patients (9128 
patients having at least one test) generating 66494 test instances. 
 The study setting includes all healthcare service organizations in the state of 
Minnesota that delivered health services to the defined study population and were 
reimbursed for services by the Minnesota Department of Human Services under the 
Medicaid program.  Care settings included hospitals, emergency rooms, medical 
centers, outpatient and primary clinics, nursing homes and other long term care facilities, 
transportation assistance, public health agencies and other non-profit organizations. 
CHC-MN and its primary and specialty care network affiliates included in the 
	   55	  
demonstration project provided approximately 30% of the total health service costs to 
the study population.  CHC-MN and its network affiliates accounted for approximately 
70% of test order volume in the population.   
 EHR adoption is high within the provider population serving study patients.  The 
2013 e-Health Survey conducted by the Minnesota Department of Health notes that 87% 
of clinics and 96% of hospitals, labs and local health departments have adopted 
electronic health record technology or equivalent HIT (MDH, 2013 a,b). The Department 
of Human Services provided patient and submitted claims data for all covered care paid 
by Medicaid and provided to the patient cohort, including claims submitted by healthcare 
organizations or radiology and lab services, for testing purposes.  EHR utilization data 
was provided by the Minnesota Department of Health. 
 The unit of analysis was the test instance.  The outcome variable was a binary 
variable identifying the instance as a repeat test instance (0/1).   Potential adjusting risk 
factors were identified based upon known and potential patient, physician and test 
factors that may impact repeat test instances in adult populations including patient 
demographics (age, sex and residence); patient health status (number of chronic 
conditions, general health status, number of health systems used and total patient test 
volume); and approach to care (facility type, test type) (Van Walraven, 2003; Zhi, 2013; 
Knighton, 2014).  Patient general health status was measured by the resource utilization 
band classification system devised using the Johns Hopkins ACG system (Johns 
Hopkins, 2009).  The ACG system was designed to measure multi-morbidities and has 
been shown to have a strong correlation with overall patient health (Starfield, 2011). 
 Use of a single health system was defined as a binary (patient use of one health 
system for care or patient use of more than one health system for care).  An important 
characteristic of a single health system is the presence of a single electronic health 
record that contains all patient data. Services by clinicians were based upon the national 
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physician identifier (NPI) code for the provider receiving payment for services (n=447).   
Instances were then individually reviewed and grouped by health system (n=292 health 
systems), each with a unique electronic health record instance. Univariate and 
multivariate logistic regression were deployed to test for significant associations between 
explanatory variables and the outcome variable.   	  
RESULTS 
 The general characteristics of the population are noted elsewhere (Knighton, 
2014).  Summarizing the repeat test instances in this population, the majority of repeat 
test instances were consistently within the same facility type as the index instance, with 
the percentage ranging from 48.10% for other facility types to 90.99% for outpatient care 
as noted in Table 13.   
 
Table 13.  Proportion of repeat test instances by index facility type 
 
	    
  
 Total test instances involving inpatient, outpatient and primary care and other 
facility type pairings with the same facility type were 66494 with 15456 of these repeat 
test instances for an overall risk of repeat test instances of 23.24% as noted in Table 14. 
Examining test volumes by index facility type, the significant majority of test instances 
were performed in outpatient settings (72.91%) followed by primary care settings 
(20.75%).  Hospitals generated a small portion of total test transactions in this sample 
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(2.49%) but had an observed repeat risk that was about two times the risk of the other 
three facility types in the study  47.59% versus 22.62% for the remaining population).   
 
 
 
Table 14.  Risk of repeat test instances by index facility type – pairing same facility 
 
 
 To understand the effect of facility type on the association between health 
system use and risk of multiple test instances, the index facility type was stratified to 
examine the odds of repeat test instances when the pair is the same facility type. The 
multivariate logistic regression models within each facility type where both the index test 
and repeated test were generated from the same facility type are noted in Table 15. 
Significant covariates associated with the risk of repeat test instances in each model 
included age, residence, patient health status, health plan type and overall patient test 
count with some variation in significance level by facility type pairing.  
 With inpatient facilities, the odds of repeat test instances were lower when the 
subsequent test instance was from a different health system [adjusted OR 0.58 (95% CI: 
0.45-0.74)].  Within the outpatient facilities, health system status did not have a 
significant effect [OR 1.04 (95% CI: 0.99-1.09)]. Within the primary care facilities, the 
effect of different health systems increased the odds of multiple tests instances [OR 1.32 
(95% CI: 1.18-1.47)]. 
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Table 15.  Multiple logistic regression analysis of risk of repeat test instances 
within facility type 
 
 
   
 
DISCUSSION 
 Facility type has a significant impact on the risk of repeat test instances.  
Inpatient care is associated with higher risk of test repetition than outpatient and primary 
care settings (Valenstein, 1988; Bates, 1998b; Van Walraven, 2003).  The study 
confirmed similar findings in a pediatric population. The working assumption for this 
study was that differences in repeat testing by facility type is due to care intensity with 
higher care intensity environments such as inpatient settings associated with a higher 
risk of test repetition.  Higher intensity settings such as tertiary care hospitals are 
characterized by higher volumes of services for a given patient encounter.  
Understanding the effect of facility type on patients using more than one health system 
and the risk of repeat test instances allows for better characterization of the potential 
effect that multiple health system use (and presumably accessible prior test results) may 
have on the risk of repeat test instances. Understanding the effect by facility type can aid 
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in targeting tangible opportunities from EHR deployment and health information 
exchange to improve quality and lower cost of medical testing. 
 In this study inpatient facilities had the highest risk of repeat test instances 
(47.59%).  That high risk may be explained at least in part by the high-intensity nature of 
care given in inpatient settings for acute patient conditions.  Physician ordering practices 
in the treatment of acute conditions include the use of panel-based ordering, standard 
inpatient order sets associated with standard workflows to monitor patient status (Mello, 
2010; Epstein, 1986; Williams, 1982; McGillvray, 1993; Bugter-Maessen, 1996; Griffith, 
1997).  As this study reports, the highest percentage of repeated tests occurred in 
inpatient facilities with approximate half that rate occurring in outpatient and primary care 
settings. This further suggests that when analyzing repeat test instances, facility type 
may be a surrogate measure for care intensity and important risk factor. 
 By examining only within inpatient facility pairings  (in effect, eliminating the 
impact of differential care intensity across facility types on risk of repeat test instances), 
patients receiving care in more than one health system had a significantly lower risk of 
repeat test instances than patient receiving all care within the same health system 
[adjusted OR 0.58 (95% CI: 0.45-0.74)].  One explanation for this finding may come from 
understanding the underlying patient population.  Children who receive care at children’s 
hospitals such as CHC-MN are generally more infirm, with greater risk of multiple 
comorbidities, chronic conditions and more severe medical needs than children receiving 
inpatient care at other hospitals included in this study’s data (Meurer, 1998; Merestein, 
2005).  Over 80% of the inpatient repeated test pairs were within CHC-MN; a tertiary 
care facility with a higher intensity of care  As a result, risk of repeat test instances within 
the same health system may be higher in this study population because patients that are 
sicker, with more chronic comorbid conditions, are more likely to return to CHC-MN for 
care rather than another non-CHC-MN facility. A population of children with more severe 
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comorbid conditions is more likely to require ongoing medical testing during the period of 
study. This was supported by the regression analysis that demonstrated that the 
likelihood of a repeated test instance was positively related to the severity ranking of the 
patient’s health.  
 Another explanation may arise from the fact that a majority of inpatient care in 
this study population was delivered by a single children’s health system (CHC-MN). The 
risk of repeat test instances may be higher in CHC-MN due to physician and hospital 
practices regarding the use of medical testing. Health information technology enables 
innovation but only to the extent that HIT availability aligns with the human decision-
making needs of an organization.  Evidence suggests that physicians will seek 
information but only if its deemed to be relevant to the decision at hand, reliable in terms 
of information quality and timely (Andrews, 2005; Coumou, 2006).  For example, 
clinicians may have accessible test results within an EHR but still elect to repeat tests as 
a matter of preference.  That preference may be based on the perceived  relevance and 
reliability of the test data and/or health system policy that encourages clinicians to repeat 
tests using only health system resources.   
 Finally, another potential explanation may be that there is some other 
confounding factor associated with both availability of prior test results and health 
system use in inpatient-inpatient pairings that is impacting results.  Additional data 
regarding the risk of repeat test instances when pairing inpatient instances with non-
inpatient instances was not available but may prove useful in better explaining this 
particular finding.  
 Outpatient index test instances were the most common type (72.91%) due to the 
volume of outpatient activity within this particular patient population.  Risk of repeat test 
instances was lower in outpatient types (24.27%) than inpatient settings. Lower risk was 
due at least in part to the nature of conditions treated in an outpatient setting and the 
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resulting lower intensity of care provided to treat these conditions which impacts the 
need for repeat test instances.  The study revealed a higher, though only marginally 
significant risk of repeat test instances [OR 1.04 (95%CI:0.99-1.09)] when patients used 
more than one health system.  This may suggest that a large portion of the significant 
difference in risk of a multiple test is associated with facility type (and by extension 
potential differences in intensity of care by facility type mentioned earlier) and may not 
be a result of lack of access to prior test results in outpatient facilities. 
 Primary care index test instances were the second most common type (20.75%).  
Risk of repeat test instances in primary care facility types was lower (18.81%) than in  
inpatient or outpatient settings.  This may be due at least in part to the nature of 
conditions treated in a primary care settings and the resulting lower intensity of care 
provided to treat these conditions.  Similarly, the number and type of tests (both lab and 
radiologic) are also more limited in these settings.  Within the primary care facility type, 
the study revealed a significantly higher risk of repeat test instances [OR 1.32 
(95%CI:1.18-1.47)] for multiple health system use.  This suggests that the availability of 
prior test results in primary care settings may have potential to lower medical test 
utilization by making prior test results available to clinicians via an electronic health 
record or health information exchange. 
 
LIMITATIONS 
 There are limitations to these study results.  The cohort being studied is based 
upon an attribution formula that assigns patients to the ACO based upon (1) participation 
in a complex care coordination program in place (selection of CHC-MN to receive care) 
and (2) plurality of care given at a children’s hospital/clinic.  Given that patients can elect 
where they receive a majority of their care, patients in effect self-select to the attributed 
population.  This may impact the generalizability of external validity of the study results.  
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Children’s hospitals have a set of potentially distinct characteristics from general 
hospitals including the setting, patient demographics, the nature and severity of 
conditions treated and distinct protocols or pathways in place [Meurer, 1998; Merestein, 
2005 ]. Similarly, selection to the study cohort is based upon an attribution formula 
discussed earlier.  Under this attribution formula, patients are included in the cohort 
based upon receiving a plurality of primary care from CHC-MN and by extension, its 
specialty, outpatient and inpatient services.  Care should be taken in applying these 
results across a general pediatric population. 
 Limitations in the secondary use of Medicaid claims data for research are cited 
by some as problematic when it comes to claim accuracy and the lack of clinical 
specificity with regards to diagnoses and underlying test results (Hsia, 1988; Seiber, 
2007; Chisholm, 2009; HHS-CMS, 2013).  Standard audit processes for testing Medicaid 
claims error rates occur annually.  The PERM (Payment Error Rate Measurement 
program) is sponsored by CMS and involves state evaluations on a rolling three-year 
test cycle.  As of the 2010 test cycle (which includes Minnesota), the national error rate 
for payment was 1.89% +/- 0.62%. (range from 1-3%).  State results range from 0.6 to 
3.8%.   Overall, Medicaid views these national results optimistically suggesting that no 
systemic problems exist in the results (Chisholm, 2009).  Enrollment continuity, often 
cited as a problem in using Medicaid data, was addressed by limiting the population to 
those patients who were enrolled for at least 12 months (Crystal, 2007). Regarding the 
lack of complete information, such limitations are more a function of the nature of the 
study being conducted than of the underlying limitations of the data (Dumbkowski, 2012; 
Cooke, 2013).   For purposes of this evaluation, the population-based approach to this 
study should limit the effect of limitations in the use of Medicaid claims data on the 
results of the study. 
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 The statistical methods used for this study do not fully address the impact of 
correlated data on study results.  Naturally occurring groups such as patients and health 
systems may have more similar observations than different groups. The lack of 
independence between individual study samples (in this case, test instances) may lead 
to differences in the standard errors that can impact study results (Hanley, 2003; 
Sainani, 2010). Several mitigating factors may reduce the potential effect of clustering on 
these study results. The primary explanatory variable (patients who use one health 
system versus patients using more than one health system) was already partially 
aggregated to weight for the effect of patient clustering.  However, further analysis is 
required to fully account for the impact of correlated data on study results.  
 Changes in the approach to care delivery resulting from the presence of the 
accountable care agreement could influence study results. While agreement terms are 
confidential, under the agreement CHC-MN is increasingly accountable for the total cost 
of care of this patient population during the term of the agreement.  As part of conducting 
this study, the author performed a complete review of the agreement to assess material 
terms or conditions that might impact study results.  No material issues were noted.   
 
 
CONCLUSIONS 
 Facility type can have a significant impact on the risk of repeat test instances and 
may act as a surrogate measure for care intensity.  The rates of such instances vary 
substantially among facility types.  Furthermore, within the primary care facility type, the 
health system effect remained, suggesting that patients receiving care from more than 
one health system using separate electronic health records systems impacts the risk of 
repeat test instances.  Further research is needed to understand this effect when 
patients move between facility types.  These results provide preliminary evidence of the 
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potential benefits of leveraging health information technology, including health 
information exchange, to lower test utilization and improve quality of care in pediatric 
populations. 
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SUMMARY 
Background 
Evidence exists that a substantial number of medical tests may be redundant.  One 
identified source of potential redundancy may come from a lack of access to prior test 
results available through an accessible electronic health record (EHR) when patients 
move between health systems. In Minnesota, lead testing in children is performed by a 
mix of healthcare organizations and public agencies.  No queryable central information 
repository exists for sharing patient lead test results among these organizations. The 
objective of this study is to determine whether patients receiving care from more than 
one health system is associated with repetitive lead testing in children.  Repeat testing 
may be due in part to a lack of clinician access to prior screening or diagnostic test 
results, making the repeat test necessary but potentially redundant or inconsistent with 
recommended patterns of care.  If so, then access to a common electronic health record 
or queryable information solution may lower the incidence of certain lead test repetition. 
 
Methods 
A retrospective cross-sectional design was used to measure initial and repeat test 
instance pairs.  The population-based study consisted of a Medicaid population cohort of 
12436 children (n=1856 patients with at least one lead test) defined under a three-year 
demonstration project agreement between Children’s Hospitals and Clinics of Minnesota 
(CHC-MN) and the Minnesota Department of Human Services (DHS) from 2012 to 2014. 
The study setting included all healthcare service organizations in the state of Minnesota 
that delivered health services to the defined population and were reimbursed for services 
by the DHS under Medicaid. Criteria for identification of problematic repeat lead testing 
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was based upon review of literature and discussions with CHC-MN clinicians. Logistic 
regression methods were used to test for significant associations.  
  
Results 
A total of 2069 lead test instances were identified.  Overall test repetition during the 
study period accounted for 10.29% (213 repeat tests) of the total lead test instances. 
Based upon criteria developed, approximately 50% of the repeat tests in this study were 
identified as problematic, representing 5.12% of the lead tests performed on this 
population in one year.  Separately it was noted that 35.0% (n=955) of eligible children 
did not receive at least one lead test. Repeat tests performed in different health systems 
on different EHR platforms than the initial tests were 6.49 times more likely [adjusted OR 
6.49 (95%CI: 2.825-14.925)] to be problematic than if the repeat and index test were 
performed within the same health system with a single accessible electronic health 
record.  
Conclusions 
A significant portion of repeat lead testing may be problematic.  Use of a single health 
system with prior lead test results accessible through a common electronic health record 
significantly impacts the level of problematic testing performed. Introduction of 
accessible prior test results through a single queryable information repository, or through 
the exchange of health information, may reduce problematic lead testing. Future 
Medicaid accountable care agreements between the state Medicaid program and 
participating health systems should include clear population accountability for performing 
lead or other test screenings to improve patient safety and lower the cost of care.  
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BACKGROUND 
 Medical testing, including laboratory and imaging tests, is costly with an 
estimated 4.3 billion tests performed in the US annually at a cost of $65 billion 
(Alexander, 2012).   Evidence exists that a substantial number of these tests may be 
redundant (Van Walraven 1998; Bates, 1998b). One source of potential redundancy may 
come from a lack of access to prior test results available through an accessible EHR 
when patients move between health systems (Thomas, 2000; Van Walraven, 2006; 
Gupta 2010). Previous study results suggest that the odds of repeat test instances of the 
same test increase for pediatric patients that receive care from more than one health 
system (Knighton, 2014). 
 One area of current interest is the use of lead tests for the screening, diagnosis 
and monitoring of elevated blood lead levels (EBLLs) in children.  Today at least 4 
million households have resident children that are being exposed to high levels of lead 
(HHS-CDC, 2014c). While any level of lead in the blood is potentially harmful, 
approximately half a million U.S. children ages 1-5 have blood lead levels above 5 
micrograms per deciliter (mcg/dL), the reference level at which the CDC recommends 
interventions be initiated to lower EBLLs (HHS-CDC, 2014b).  This level is based on the 
population of children between the ages of 1 and 5 years in the U.S. who are in the top 
2.5% of children when tested for lead in their blood.  Nationally, over the past ten years, 
an average of 3.7 million children were tested annually (HHS-CDC, 2014c).  In the State 
of Minnesota in 2012, approximately 2600 children were identified as having EBLLs with 
255 confirmed cases with EBLL>10µg/dL.  This represents 3.06% of the population 
tested and 0.6% of the population of children in Minnesota less than 72 months old 
(MDH, 2013c; HHS-CDC, 2014c). 
 Some repeat testing is required to properly screen, diagnose, treat and monitor 
patients for EBLLs.  Medicaid guidelines require that all Medicaid recipients be tested for 
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elevated lead levels at 12 and 24 months of age as part of an effective screening 
program.  This policy is due to risk factors associated with elevated lead levels in 
children on Medicaid, including lower socioeconomic status associated with living in 
older homes with lead exposure (HHS-CMS, 2014a).  Children between the ages of 36 
and 72 months should also be screened if they were not screened at 12 and 24 months 
(Wengrovitz, 2009).   
 Two methods of test administration exist for screening, diagnostic and/or 
monitoring purposes.  The first method is for screening purposes is a capillary test and 
uses a point of care instrument that takes a finger prick sample.  This method is most 
commonly used in physician offices, schools, Women, Infants and Children (WIC) clinics 
and other public health organizations.  Test results are available within 3 minutes and 
can measure a range between 3.3mcg/dL and 65mcg/dL with reasonable accuracy.  
Retesting guidelines using a confirmatory venous test vary from >5-10mcg/dL for 
elevated capillary test results.  A venous lead test may also be administered as the 
primary screening method.  A venous test is considered conclusive (gold standard) in 
the diagnosis and monitoring of elevated blood lead levels (EBLLs) and is used as a 
confirmatory test following an elevated capillary test (ACCLP, 2013).  Immediate actions 
to remove the environmental sources of lead contamination can lower EBLLs. (HHS-
CDC, 2014a)  Recommended care interventions and retesting guidelines based upon 
initial screening results are noted in Table 16. 
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Table 16.  Recommended care interventions and rescreening guidelines by care 
intervention result (HHS-CDC, 2014a) 
 
 
 A 2012 national expert committee report updating new EBLL guidelines also 
encouraged efforts to facilitate data sharing between health care providers and agencies 
in an effort to efficiently screen and monitor at-risk children (HHS-CDC, 2012).  In 
Minnesota, screening and diagnostic testing for lead is performed by a mix of non-profit 
agencies, public health organizations or specialty and inpatient health care providers.  
No central queryable information repository exists for sharing lead test results among 
these organizations.  Electronic health record systems in provider organizations are the 
primary mechanism in place for the exchange of test results.  Levels of actual electronic 
information exchange between separate health systems during the study period 
remained low when exchanging health information between health systems based upon 
a recent state survey data (MDH, 2013 a,b). 
 The hypothesis is that the lack of an accessible electronic health record or health 
information technology (HIT) solution among health care providers produces a level of 
repetitive testing that results from a clinician’s lack of access to prior screening or 
diagnostic test results when patients visit more than one health system.  Lack of 
accessible test results make repeat testing necessary but potentially redundant or 
inconsistent with recommended patterns of care as noted in Figure 6.  If so, then access 
Test%Result Intervention
Retesting%
Guidelines
<5µg/dL None Rescreen%in%12%
months
>5µg/dL Caregiver%efforts%to%examine%surroundings%to%identify%and%remove%
any%sources%of%lead%contamination
Retest%in%3%
months
>15µg/dL Engagement%of%a%state%lead%risk%assessor%that%perform%an%
environmental%review%of%the%child's%residence%to%find%and%eliminate%
hazards
Retest%in%1J3%
months
>20µg/dL Engagement%of%a%state%lead%risk%assessor%that%perform%an%
environmental%review%of%the%child's%residence%to%find%and%eliminate%
hazards
Retest%in%2J4%
weeks
>45µg/dL Medical%attention Immediate
>60µg/dL Emergency%medical%attention,%potentially%including%the%use%of%
chelation%therapy%to%lower%blood%lead%levels
Immediate
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to a common electronic health record or shared information solution should lower the 
incidence of certain repetition. 
 
Figure 6.  Identifying problematic lead testing in a pediatric population 
 
To test this assumption, criteria were identified to differentiate appropriate test repetition 
from problematic repeat tests that may result from a presumable lack of clinician access 
to prior test results in a shared medical record.  The difference in problematic repeat 
testing when the index and repeat test were performed within the same health system 
was compared against problematic repeat testing when the index and repeat test were 
performed in different health systems. 
 IRB approval for this study was obtained from the Minnesota Department of 
Human Services (IRB# 280), Children’s Hospitals and Clinics of Minnesota (IRB# 1402-
022) and the University of Minnesota (IRB# 1403E49003). 
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METHODS 
 The objectives of this study were to (1) characterize repeat lead testing within the 
pediatric population, (2) identify useful criteria to identify problematic repeat tests and 
then (3) compare the odds of problematic repeat testing between repeat tests performed 
by the same health system as the index test and repeat tests performed by a different 
health system than the index test.  Criteria for identification of problematic repeat lead 
testing was based upon review of literature and discussions with internal clinicians at 
CHC-MN. 
 The following measurement constructs were defined for purposes of the study.  A 
“lead test instance” was the unit of measure for this study and was defined as any 
medical test performed and invoiced via claim by a clinician in a home care, primary 
care, outpatient, emergency room, inpatient, nursing home or other public health setting 
to provide information on a patients health status for screening, diagnosis, treatment or 
health maintenance purposes.  A “repeat lead test” was defined as a diagnostic, 
screening or monitoring test that follows a preceding instance of the same test (index 
test) for the same patient during the study period.   Definition of a repeat test required an 
exact match of the index test and repeat test CPT code.  Venous and capillary test types 
were not separately specified for purposes of matching index and repeat tests.  The 
“probability of test repetition” was defined as the probability of a repeat test during the 
study period (repeat volume/total volume).  Repeat counts were also aggregated by 
unique patient. “Days to next test instance” was defined as the number of days 
between the index test and the next test instance (next test instance date – index test 
date).  A “health system” was defined as a network of clinics, hospitals, specialty 
programs and long-term care facilities under a common ownership structure designed to 
deliver care.  For purposes of this study, “accessible prior test results” were deemed 
accessible to the clinician via a common electronic health record if the subsequent 
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medical test was ordered by a clinician operating within the same health system or 
health agency that ordered the index test. Use of the same health system was 
considered a reasonable proxy for accessibility given that each health system in 
Minnesota has its own common electronic health record shared by the individual health 
system locations.  This was confirmed by reviewing Minnesota Department of Health 
data regarding EHR use (MDH, 2013 a,b). 
 “Problematic repeat lead tests” were defined as repeat tests with one or more 
characteristics that may suggest a higher risk of test redundancy.  The definition of a 
problematic repeat test was based upon published clinical guidelines and discussions 
with physicians at CHC-MN.   Patient age, test type, days between tests and diagnosis 
coding were used as characteristics to identify repeat test sequences that are 
inconsistent with recommended patterns of care and thus problematic as follows:   
• Patients receiving three or more capillary tests within one year.  The presence of the 
second capillary test implies that the first test was within normal levels.  Otherwise, 
the patient should have received a venous test to confirm the diagnosis of EBLL.  
The presence of a third capillary test implies that the first two tests were within 
normal limits meeting the testing requirements.  A third or fourth capillary test is 
problematic and would have a high probability of being redundant. 
• Patients who received a base capillary test followed by a second base capillary test 
in less than 9 months.  Performing a second base capillary test after an initial test 
reasonably implies that the first test results were normal. Guidelines suggest that 
sufficient time between the first and second test should be given to ensure that the 
second test has value for screening purposes. 
• A capillary test that follows a venous test within 9 months.  A capillary test following a 
venous test would imply that the initial venous test was normal (some care givers 
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give only a venous test for lead screening). Guidelines suggest that sufficient time 
between the first and second test exist to ensure that the second test has value for 
screening purposes. 
• Repeat capillary test on any child <18 months old.  A repeat capillary test would only 
be reasonable if the first test given at approximately 12 months of age was normal.  
Guidelines suggest that sufficient time between the first and second test exist to 
ensure that the second test has value for screening purposes. 
• Repeat test within 90 days for a patient with no diagnostic indication of elevated 
blood lead levels in the index or repeat encounter based upon ICD-9 diagnostic 
coding.  A listing of these conditions is noted in Table 17. 
 
 
Table 17.  Diagnoses, signs and symptoms associated with elevated blood lead 
levels by ICD-9 code (Aetna, 2014) 
 
 
  
 The study was a retrospective cross-sectional design.  The population for this 
study was a Medicaid total population cohort of 15,886 children defined under a three-
year, demonstration project agreement between Children’s Hospitals and Clinics of 
Minnesota (CHC-MN) and the Minnesota Department of Human Services (DHS) running 
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from 2012-2014. CHC-MN is part of a distinct class of hospitals known as children’s 
hospitals that exist to exclusively serve the needs of children and adolescents.  
Children’s hospitals are characterized by expertise in treating children, including children 
with rare diseases, and in providing greater attention to psychosocial support for children 
and families. 
 Patient attribution to the Medicaid patient cohort was a based upon (a) Medicaid 
enrollment status and (b) whether the patient received a plurality of their care through 
CHC-MN primary care clinics.  Patient attribution for purposes of this study was 
measured as of December 31, 2013.   All lead test instance activity for the previous 12 
months ending September 30, 2013 was included in the data files and analyzed.  For 
purposes of this study, all patients that did not remain on Medicaid for the complete 
period of the study were excluded.   The final study population cohort includes 12436 
patients (9153 patients having at least one test).  Of this population, 1856 received at 
least one lead test during the study period.   
 The study setting includes all healthcare service organizations in the state of 
Minnesota that delivered health services to the defined study population and received 
reimbursement for services by the Minnesota Department of Human Services under the 
Medicaid program.  Settings include hospitals, emergency rooms, medical centers, 
outpatient and primary clinics, nursing homes and other long term care facilities, 
transportation assistance, public health agencies, other non-profit organizations and so 
forth. 
 CHC-MN and its primary and specialty care network affiliates included in the 
demonstration project provided approximately 30% of the total health service costs to 
the study population.  CHC-MN and its network affiliates account for approximately 70% 
of test order volume.  EHR adoption is high within the provider population serving study 
patients.  The 2013 e-Health Survey conducted by the Minnesota Department of Health 
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notes that 87% of clinics and 96% of hospitals, labs and local health departments have 
adopted electronic health record technology or equivalent HIT (MDH, 2013 a,b). 
 The Department of Human Services provided Medicaid enrollment and 
claims/encounter patient data for all medical care paid by Medicaid and provided to the 
patient cohort.  Lead test instances were coded for reimbursement purposes at least two 
ways, based upon the test type and how the test is administered and analyzed.  Tests 
taken on site and analyzed locally from a Clinical Laboratory Improvement Amendment 
(CLIA) organization were generally coded as a single line item that includes both the 
cost of administering and analyzing the test (CPT Code – 83655).    Tests taken by a 
health practitioner and then sent to another lab for analysis are coded as either CPT 
36415 (venous) or 36416 (capillary).   
 For purposes of classifying lead test instances as either venous or capillary set 
criteria was used. Tests that were sent offsite were coded based upon the 
accompanying CPT code for test administration noted in the encounter.  If tests that 
were coded as lead only with no administration (generally onsite tests), they were 
classified as venous if the test was performed at CHC-MN (their standard procedure for 
lead testing at CHC-MN is to take a venous draw), if another venous blood draw was 
taken during the same visit, or if results were directed to a lab.  If none of these criteria 
were met, the test was identified as capillary.  Claims data was coded by provider using 
the national provider identifier.  For purposes of this study, all providers were 
categorized by health system as defined above.   
 Descriptive statistical methods were deployed to characterize the population and 
to  identify potential risk factors for repeat test instances in children.   The outcome 
variable was a binary variable identifying the repeat instance as a either a problematic or 
non-problematic repeat test instance (0/1).  The principal explanatory variable of interest 
was binary and identified whether the location of the repeat test differed from the index 
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test.  Other potential explanatory variables were identified for testing based upon 
previous work as well as known and potential patient, physician and test factors that 
could impact repeat test instances in adult populations including: patient demographics 
(age at start of study, age at time of test, sex and residence); patient health status 
(number of chronic conditions, general health status and total patient test volume); and 
approach to care (care location, test type) (Van Walraven, 2003; Zhi, 2013; Knighton, 
2014).  Patient general health status was measured by the resource utilization band 
classification system devised using the Johns Hopkins ACG system (Johns Hopkins, 
2009).  The ACG system was designed to measure multi-morbidities and has been 
shown to have a strong correlation with overall patient health (Starfield, 2011).  
Multivariate logistic regression was used to test patient characteristics associated with 
lead test repetition for significance and to measure the effect of common health system 
use on the incidence of repeat testing.  	  
 
RESULTS 
 The patient population included 15887 patients attributed to the accountable care 
population as of December 31, 2113, of which 12436 patients were enrolled in Medicaid 
for the entire study period.  As portrayed in Table 18, 1856 patients in the population 
(14.92% of the total population) had at least 1 lead test during the study period.  A total 
of 2069 lead test instances were performed (venous – 58.82%; capillary – 41.18%) 
representing 3% of total test instances for the population.  Mean age at start of study for 
children receiving at least 1 lead test was 1.82y (median 1.32y).  Over 80% of patients 
receiving a lead test were between the ages of 0-4 at the time the test was administered.  
47.35% of total patients (n=12436) within the overall study population between the ages 
of 0-4 received at least 1 lead test during the study period.  Screening compliance (at 
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least one lead test performed) among the eligible children (age between 0 and 540 days 
at the start of the study period) was 64.99% (1114 tests/1714 eligible children).  
Reviewing patient instance/diagnostic data, no patients were identified as receiving 
chelation treatment during the study period (ICD 9: 984.0-984.9 – Toxic Effect of Lead 
and Its Compounds).  Overall test repetition accounted for 10.29% (213 repeat tests) of 
the total lead test instances.  Lead instance volume per patient during the study period 
ranged from 1-4 tests.  Of the 213 repeat tests, 19.72% involved an index capillary test 
followed by a repeat capillary test.  26.76% involved an index capillary test followed by a 
repeat venous test (total index capillary tests n=99).  Of the 213 repeat tests, 14.08% 
involved an index venous test followed by a repeat capillary test.  39.44% involved an 
index venous test followed by a repeat venous test (total index venous test n=114).  
 Using multivariate logistic regression to test patient characteristics significantly 
associated with problematic test repetition included age at visit [OR 0.69 (95%CI: 0.54-
0.90)] and urban residence [OR 0.35 (95% CI: 0.16-0.78)] Most common observed index 
order locations for a repeat test included outpatient settings (49.29%) followed by 
primary care (42.7%) and public health (7.5%).  A similar pattern existed for reorder 
locations with outpatient setting highest (62.4%) followed by primary care (33.33%) and 
public health (4.2%).  Mean days to next test instance between the index and repeat test 
were 123d (median 95d).  Stratifying by index test type between venous or capillary, 
observed time to repetition was longer for index venous tests (137d) than for index 
capillary tests (107d).  A similar difference was found when examining repeat test types 
with observed venous mean test time to repeat (126d) longer than for capillary tests 
(118d).  
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Table 18.  Study population characteristics – overall and for patients with at least 
one lead test 
 
 The study results suggest that a level of problematic repeat tests exist when 
examining the study population.  The level of repeat testing that is problematic is 
approximately 50% of the repeat population in this study.  Results of the profile are 
noted in Table 19. 
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Table 19.  Count of problematic repeat lead tests 
 
Three types of inappropriate testing were identified through the study - excess 
tests that appear to be repeated more than necessary and tests taken too soon following 
the initial test thus limiting the test’s informational value in care.  This level of problematic 
lead testing indicates that 106 lead tests out of 2069 performed during the study period 
were problematic, representing 5.12% of the tests performed on this population in one 
year.  The other form of inappropriate lead testing identified was undertesting.  In a 
separate analysis, it was noted that 35.0% (n=955) of eligible patients in the population 
did not receive at least one lead screening during the study period.  On an unadjusted 
and adjusted basis, repeat tests performed at different systems on different EHR 
platforms were 4.61 times more likely [95% CI: 2.58–8.26] and 6.49 time more likely 
[95% CI: 2.83-14.93] to be problematic, respectively, than if the repeat and index test 
were performed within the same health system on a common platform.    
 
DISCUSSION 
 Test repetition is expected in lead testing for screening, diagnostic and 
monitoring purposes.  Overall test repetition accounted for 10.29% (213 repeat tests) of 
the total lead test instances.  Criteria for identifying problematic lead screenings was 
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proposed by examining characteristics of the test administration including child age, 
days between tests and the sequencing of tests administered to detect potential 
problematic repeat tests.  Reasonable test sequences, consistent with evidence-based 
standards of care, provide evidence of an underlying process of care for screening, 
diagnosis and treatment.  Evidence of seemingly random test patterns indicate a 
possible lack of coordination in patient care suggesting that a test is problematic and has 
a higher risk of being redundant.. 
 The results suggest that 50% of repeat lead tests within this particular test 
population were problematic in that either the test appeared excessive or the repeat test 
was performed too soon after the index test instance, limiting its clinical value.  When 
examining problematic repeat tests by health system, repeat test instances performed in 
a different health system than the index test instance using different EHR instances were 
6.5 times more likely to be problematic than repeat transactions performed within the 
same system on a common EHR instance [95% CI: 2.83-14.93] 
 These results provide evidence regarding the hypothesis that the lack of an 
accessible electronic health record or queryable health information technology solution 
between health agencies and health care providers results in significantly higher levels 
of problematic repeat testing.  Higher levels of repeat testing may be due to a clinician’s 
lack of access to prior screening or diagnostic test results, making a repeat test 
necessary, but premature or potentially redundant, in providing an appropriate process 
of care. 
 The fact that each health system has a distinct electronic health record system 
makes it particularly difficult to separate the impact of accessible test results in an 
electronic health record from the effect of each health system’s policies and practices on 
the incidence of repeat test instances.  This difficulty gives rise to a potential alternative 
explanation of the results.  Health information technology enables innovation but only to 
	   82	  
the extent that HIT availability aligns with the human decision-making needs of an 
organization.  Evidence suggests that physicians will seek information but only if its 
deemed to be relevant to the decision at hand, reliable in terms of information quality, 
and timely (Andrews, 2005; Coumou, 2006).  For example, clinicians may have 
accessible test results from another health system but still elect to repeat tests, as a 
matter of preference given concerns regarding the relevance and reliability of the test 
data, or due to health system policy that encourages clinicians to repeat tests using only 
health system testing resources. The impact is that some portion of the incremental test 
repetition identified through this study may result from these mechanisms, making it 
difficult to estimate the effective impact that making prior tests results accessible through 
either a single electronic health record or through the health information exchange would 
have on the incidence of repeat test instances.   Future study is required to separate the 
effect of health system policy from the impact of accessible prior test results on the level 
of repeat test instances.   
 An argument could be made that a level of unnecessary repetition is a 
reasonable incurred cost to ensure that all children are being properly tested.  However, 
the results noted that roughly 1/3rd of the eligible population that should have received at 
least one lead test during the study period did not.  This suggests that current methods 
to coordinate lead testing across the state population may not be adequate to ensure 
that at-risk children are receiving appropriate care.  
 
LIMITATIONS 
 There are limitations to these study results.  The cohort being studied is based 
upon an attribution formula that assigns patients to the ACO based upon (1) participation 
in a complex care coordination program in place (selection of CHC-MN to receive care) 
and (2) plurality of care given at a children’s hospital/clinic.  Given that patients can elect 
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where they receive a majority of their care, patients self-select to the attributed 
population.  This may impact the generalizability of the study results. 
 Children’s hospitals have a set of potentially distinct characteristics from general 
hospitals including the setting, patient demographics, the nature and severity of 
conditions treated and distinct protocols or pathways in place (Meurer, 1998; 
Merenstein, 2005).  Care should be taken in applying these results across a general 
pediatric population. 
 Limitations in the secondary use of Medicaid claims data for research are cited 
by some as problematic when it comes to claim accuracy and the lack of clinical 
specificity with regards to diagnoses and underlying test results (Hsia, 1988; Seiber, 
2007; Chisholm, 2009; CMS, 2013).  Standard audit process for testing Medicaid claims 
error rates occur annually.  The PERM (Payment Error Rate Measurement program) is 
sponsored by CMS and involves state evaluations on a rolling three-year test cycle.  As 
of the 2010 test cycle (which includes Minnesota), the national error rate for payment 
was 1.89% +/- 0.62%. (range from 1-3%).  State results range from 0.6 to 3.8%.   
Overall, Medicaid views these national results optimistically suggesting that no systemic 
problems exist in the results (Chisholm, 2009).  Enrollment continuity, often cited as a 
problem in using Medicaid data, was addressed by limiting the population to those 
patients who were enrolled for at least 12 months (Crystal, 2007). Regarding the lack of 
complete information, such limitations are more a function of the nature of the study 
being conducted than of the underlying limitations of the data (Dumbkowski, 2012; 
Cooke, 2013). For purposes of this evaluation, the population-based approach to this 
study should mitigate the effect of any limitations in the use of Medicaid claims data on 
the results of the study. 
 In some circumstances, the criteria developed for measuring problematic tests 
may incorrectly identify an appropriate test as problematic.  For example, a patient 
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receiving a repeat test within 90 days without evidence of previous elevated blood lead 
levels based upon ICD-9 terminology may be receiving a repeat test because a family 
member was identified as at risk.  While rare, these situations may impact the criteria’s 
case detection sensitivity.  An exhaustive list of symptoms, conditions or diagnoses that 
would rule out a problematic test were included to adjust for this risk. 
 The statistical methods used for this study do not fully address the impact of 
correlated data on study results.  Naturally occurring groups such as patients and health 
systems may have more similar observations than different groups. The lack of 
independence between individual study samples (in this case, test instances) may lead 
to differences in the standard errors that can impact study results (Hanley, 2003; 
Sainani, 2010). Several mitigating factors may reduce the potential effect of clustering on 
these study results.  Mitigating factors that reduce the effect of correlated data in this 
study include the number of patients with two tests (10% of the study population) and the 
number of patients with more than two tests (less than 1% of the study population).  
However, further analysis is required to fully account for the impact of correlated data on 
study results.  
 Changes in the approach to care delivery resulting from the presence of the 
accountable care agreement could influence study results. While agreement terms are 
confidential, under the agreement CHC-MN is increasingly accountable for the total cost 
of care of this patient population during the term of the agreement.  As part of conducting 
this study, the author performed a complete review of the agreement to assess material 
terms or conditions that might impact study results. No material issues were identified.  
 
CONCLUSIONS 
 Lead test repetition is appropriate in providing proper screening, diagnostic and 
monitoring care.  The results highlight the impact that fragmented preventive care, 
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delivered across health system with limited information sharing, can have on the cost 
and quality of care.  Evidence from this study indicates that a portion of lead testing is 
problematic based upon a comparison of test sequencing and timing within established 
guidelines.  Problematic repeat tests include tests that are repetitive or unnecessary as 
well as tests repeated too soon following the index test, marginalizing the test value.  
The results suggest that approximately 50% of repeat lead testing performed is of 
questionable clinical value when measured against guidelines and that access to a 
common information system may lower problematic testing.  Prior lead test results 
available for patients receiving care within one health system appear to reduce the risk 
of problematic lead testing. Further research is needed to separately evaluate the 
effectiveness of a common queryable information system given the potential impact that 
organization policy and practice may have on test repetition. Future Medicaid 
accountable care agreements between the state Medicaid program and participating 
health systems might include clear population accountability for performing lead or other 
test screenings to improve patient safety and lower the cost of care.  
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OVERALL DISCUSSION AND CONCLUSIONS 
 Evaluating the benefits of health information technology is a complex 
undertaking.    These initial studies suggest the potential for electronic health information 
technology to impact health care delivery for children, including the potential to reduce 
patient cost and improve care quality by reducing inappropriate test instances.   
 The underlying hypothesis for these population-based studies was that a portion 
of repeat test instances within a pediatric population results from a lack of clinician 
access to prior test results observable within an electronic health record.  Clinicians with 
access to prior test results observable through an electronic health record will order 
fewer repeat tests than clinicians who do not have access to prior test results.  To test 
this hypothesis, four specific aims were identified.  First, to characterize the repeat test 
instances within a pediatric population and to measure the effect of health system use as 
a proxy for accessible prior test results on the odds of repeat test instances across all 
test types.  Second, to measure the effect of facility type on the association between 
health system use and repeat test instances.  Third, to define a reasonable criteria for 
problematic repeat lead tests.  Fourth, to measure the effect of multiple health system 
use as a proxy for accessible prior test results on the incidence of problematic repeat 
lead testing. 
 In characterizing repeat test instances as noted in the first paper, the study 
results identified several risk factors associated with repeat test instances in children 
including age, residence, health status, health plan type and facility type. It was 
demonstrated that a test instance performed on patients using multiple health systems 
was more likely to be a repeat test instance for certain facility types than for patients 
having all test instances performed within the same health system where prior test 
results were potentially accessible.  It was also demonstrated that the incidence of 
repeat test instances will be higher among patients who receive care across multiple 
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health systems than in patients who receives all patient care within a single health 
system..   This study contributes to our scientific understanding by characterizing several 
risk factors associated with repeat testing in children.  Of particular importance is the 
identification of an association between multiple health system use and repeat testing 
more generally in pediatric populations.  These results provide preliminary evidence 
suggesting that a level of repeat testing in pediatric populations may be associated with 
patient movement between health systems, and based upon a lack of physician access 
to prior test results, may be redundant. 
 In measuring the effect of facility type on the association between multiple health 
system use and repeat test instances in the second paper, it was found, consistent with 
studies in adults that the level of test repetition varied considerably based upon the 
facility type.  Hospital-based care was associated with a significantly higher level of 
repeat testing than outpatient and primary care.  This is due in large measure to 
differences in the intensity and underlying processes of care between facility types.  
Analyzing each facility type, contradictory results were found.  In inpatient settings, 
patients using more than one health system for inpatient care had lower repeat test 
instances than patients using a single health system.  This is due in large part to the fact 
that over 80% of patients using the same health system used CHC-MN.  Patients who 
utilize CHC-MN for inpatient care are more infirm with more chronic comorbidities.  
Consistent with the original hypothesis, a single health system and presumably a single 
health record, may prove most beneficial in controlling the risk of unnecessary repeat 
test instances in primary care settings.  Additional data regarding the risk of repeat test 
instances in patients transitioning between facility types was not available for this study 
and may prove useful in further clarifying this finding.   This paper contributed to our 
scientific understanding by confirming, consistent with adults, that repeat testing is 
associated with higher care intensity, particularly in inpatient settings.  The effect of 
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multiple health system use on increased test repetition appears more pronounced in 
primary care settings. 
 In the third paper, a common medical test was used for childhood screening and 
diagnosis of lead poisoning to further refine assumptions.  A reasonable criteria was 
used for the identification of problematic repeat lead tests and characterized the nature 
and level of problematic repeat lead tests within the population.  Approximately 50% of 
all repeat lead tests were problematic.  Through this, it was demonstrated that the 
likelihood of problematic repeat testing was meaningfully lower in situations where index 
and repeat tests were performed within one health system, presuming that physicians 
had reasonable access to prior test results.  While not conclusive these findings 
contribute strong evidence supporting the relationship between accessibility of prior test 
results available in an electronic health record or other queryable health information 
solution and physician decisions regarding the utilization of subsequent testing 
resources for a specific test.  
 
OVERALL STUDY LIMITATIONS 
 Despite these results, barriers remain to achieving the anticipated population-
based testing efficiencies associated with sharing electronic test information  The fact 
that each health care system has a separate electronic health record system makes it 
difficult to separate the impact of accessible test results from an electronic health record 
from the effect of each health system’s policies and practices on the incidence of repeat 
test instances.  This gives rise to a possible alternative explanation for these results.  
Health information technology enables innovation but only to the extent that HIT 
availability aligns with the human decision-making needs of an organization.  Evidence 
suggests that physicians will seek information but only if its deemed to be relevant to the 
decision at hand, reliable in terms of information quality, and timely (Andrews, 2005; 
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Coumou, 2006).  For example, clinicians may have accessible test results from another 
health system but still elect to repeat tests as a matter of preference given concerns 
regarding the relevance and reliability of the test data or due to health system policy that 
encourages clinicians to repeat tests using only health system testing resources. The 
impact of hospital and clinician preferences is that some portion of the incremental test 
repetition identified through this study may result from these mechanisms.  This makes it 
difficult to estimate the effective impact that making prior tests results accessible through 
either a single electronic health record or through the health information exchange will 
have on the incidence of unnecessary repeat test instances.   Future study is required to 
separate the effect of health system policy from the impact of accessible prior test 
results on the level of repeat test instances. 
 The cohort being studied is based upon an attribution formula that assigns 
patients to the ACO based upon participation in a complex care coordination program in 
place and a plurality of care is given at a CHC-MN primary care clinic.  Given that 
patients can elect where they receive a majority of their care, patients self-select to the 
attributed population.  This may impact the generalizability of the study results. 
 Children’s hospitals have a set of potentially distinct characteristics from general 
hospitals including the setting, patient demographics, the nature and severity of 
conditions treated and distinct protocols or pathways in place (Meurer, 1998; 
Merenstein, 2005).  Care should be taken in applying these results across a general 
pediatric population. 
 Limitations in the secondary use of Medicaid claims data for research are cited 
by some as problematic when it comes to claim accuracy and the lack of clinical 
specificity with regards to diagnoses and underlying test results (Hsia, 1988; Seiber, 
2007; Chisholm, 2009; CMS, 2013).  Standard audit process for testing Medicaid claims 
error rates occur annually.  The PERM (Payment Error Rate Measurement program) is 
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sponsored by CMS and involves state evaluations on a rolling three-year test cycle.  As 
of the 2010 test cycle (which includes Minnesota), the national error rate for payment 
was 1.89% +/- 0.62%. (range from 1-3%).  State results range from 0.6 to 3.8%.   
Overall, Medicaid views these national results optimistically suggesting that no systemic 
problems exist in the results (Chisholm, 2009).  Enrollment continuity, often cited as a 
problem in using Medicaid data, was addressed by limiting the population to those 
patients who were enrolled for at least 12 months (Crystal, 2007). Regarding the lack of 
complete information, such limitations are more a function of the nature of the study 
being conducted than of the underlying limitations of the data (Dumbkowski, 2012; 
Cooke, 2013). For purposes of this evaluation, the population-based approach to this 
study should limit the effect of limitations in the use of Medicaid claims data on the 
results of the study. 
 The statistical methods used for this study do not fully address the impact of 
correlated data on study results.  Naturally occurring groups such as patients and health 
systems may have more similar observations than different groups. The lack of 
independence between individual study samples (in this case, test instances) may lead 
to differences in the standard errors that can impact study results (Hanley, 2003; 
Sainani, 2010). Several mitigating factors may reduce the potential effect of clustering on 
these study results. The primary explanatory variable (patients who use one health 
system versus patients using more than one health system) was already partially 
aggregated to weight for the effect of patient clustering.  Results also demonstrated that 
the study effect remained after removing patients with more than 25 transactions where 
the impact of correlated data would be more pronounced.  However, further analysis is 
required to fully account for the impact of correlated data on study results. 
 Changes in the approach to care delivery resulting from the presence of the 
accountable care agreement could influence study results. While agreement terms are 
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confidential, under the agreement CHC-MN is increasingly accountable for the total cost 
of care of this patient population during the term of the agreement.  As part of conducting 
this study, the author performed a complete review of the agreement to assess material 
terms or conditions that might impact study results. No material issues were identified.  
 
CONTRIBUTION AND FUTURE DIRECTIONS 
 These studies make significant contributions to health informatics and to health 
services research in several important ways. Publications associated with this research 
will be submitted to the Journal of Population Health Management for consideration as 
well as to other relevant journals. 
 Population-based studies are increasingly important given changes in healthcare 
financing under the Affordable Care Act.  The use of population claims data with 
complete patient activity across all providers offered a novel glimpse into a specific 
context - the interaction of pediatric care providers with a children’s hospital system 
within a large metropolitan area.  Such contextual studies will become increasingly 
common to measure both patient health and patient use of the healthcare resources.  
Studies focused on identifying other forms of repetition within these populations that 
result from a lack of access to prior healthcare-related information may prove insightful 
in efforts to eliminate redundant care.  Such research may also prove interesting in 
measuring other forms of repetition not captured today, such as readmissions, that result 
as patients within a population move between health systems. In many cases, these 
analytic methods are scalable to increasingly larger populations of patients. 
 These studies represent a first effort to characterize the incidence of repeat test 
instances in a pediatric population along with risk factors, including patient use of 
multiple health systems.. Testing usage patterns differ between adult and pediatric 
populations making separate research into pediatric population-based management of 
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medical testing necessary, particularly if such efforts are aligned with quality and 
utilization target setting programs. Understanding risk factors for medical test repetition 
aids in subsequent efforts to identify the root causes of inappropriate testing in children 
in an effort to eliminate waste. 
 These studies introduced useful methods for measuring repetition using claims 
data, particularly in situations where clinical test results were not available.  Such 
methods are important in framing population-based management strategies to identify 
and reduce the incidence of inappropriate testing in pediatric populations.  Of particular 
note was the use of hierarchical data modeling methods for the identification of repetition 
in a population.  In addition, the approach taken to develop useful clinical criteria to 
identify problematic repeat tests can be applied as well with other tests.  
 Finally, these studies have important implications for state and national efforts to 
promote greater information sharing across physicians and health systems as a 
mechanism for reducing unnecessary healthcare expenditures.  At the federal level, 
stage 3 meaningful use criteria is currently in development with a focus on the use of 
EHR technology to improve quality outcomes and population health (HHS-ONCHIT, 
2104).  Consistent with national goals, in the State of Minnesota, statutes require 
interoperability of electronic health records by 2015 (MN Statute 62J.495).  Evidence 
quantifying the impact of prior clinical information on utilization and cost can inform these 
efforts relative to pediatric settings. Meaningful use of health information exchange 
across pediatric populations shows promise in improving care quality and lowering per 
patient cost of care.  Further research is needed to examine the impact prior clinical 
information in the form of an accessible electronic health record can have on other 
common tests and imaging procedures. 
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